Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
40766189	s-dgpabg	— (—)	11038	11851	100.00%	Distribution not available
40766189	s-dgpabg	eliau/ml (u/ml)	976	1023	0.00%
40766189	s-dgpabg	u/ml (u/ml)	391	458	0.00%
40766189	s-gliadiinipeptidit,deamidoidut,iga-vasta-aineet	u/ml (u/ml)	299	304	0.00%
40766189	s-gliadiinipeptidit,deamidoidut,iga-vasta-aineet	— (—)	5	5	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Non-invasive ventilation

1095

2287

4.57

307.65

1.1

18.89

5.21

u/ml

1.60

410

Coeliac disease

638

1316

5.36

295.62

1.4

1.1

22.11

3.35

u/ml

10.85

191

168

Irritable bowel syndrome

1060

3203

3.49

287.64

1.1

2.70

7.18

u/ml

3.52

112

456

Diseases of the digestive system

1149

4541

2.59

187.36

1.3

1.1

18.64

4.36

u/ml

8.97

232

473

Gastro-oesophageal reflux disease

1645

6772

2.14

169.59

1.1

5.43

5.29

u/ml

0.04

149

930

Other diseases of intestines

2717

8532

1.84

167.74

1.1

4.39

5.63

u/ml

0.64

317

1266

Diseases of oesophagus, stomach and duodenum

2587

8479

1.86

165.44

1.1

7.58

4.85

u/ml

1.37

269

1210

Pain in joint

1473

4438

2.16

145.70

1.1

4.65

6.00

u/ml

0.58

145

711

Autoimmune diseases

2688

7891

1.76

139.25

1.1

10.22

3.47

u/ml

5.41

340

1086

Used for control exclusion in common control thyroid runs

2535

7381

1.76

131.84

1.1

9.05

3.42

u/ml

4.45

319

1018

Autoimmune diseases excluding thyroid diseases

2481

7819

1.76

130.54

1.1

11.39

3.48

u/ml

6.59

314

1071

Autoimmune diseases excluding thyroid diseases, strict definition

2419

7630

1.76

128.63

1.1

11.57

3.38

u/ml

6.92

311

1049

Other functional intestinal disorders

1055

4423

2.26

126.76

1.1

6.59

7.44

u/ml

0.14

563

Functional dyspepsia

727

2824

2.66

125.02

1.1

7.20

6.51

u/ml

0.11

392

Dermatitis and eczema

2599

9727

1.68

119.82

1.1

5.80

5.33

u/ml

0.15

306

1320

Symptoms and signs involving the digestive system and abdomen

2276

6617

1.75

115.35

1.1

5.15

5.82

u/ml

0.28

272

981

Abdominal and pelvic pain

2260

6616

1.74

112.88

1.1

5.34

5.82

u/ml

0.20

264

980

Headache

1703

7646

1.81

106.97

1.1

5.30

5.50

u/ml

0.08

195

1114

Constipation

1880

7600

1.74

100.32

1.1

3.80

6.33

u/ml

1.75

171

1004

Other special examinations and investigations of persons without complaint or reported diagnosis

1486

4051

1.89

96.49

1.1

6.05

4.83

u/ml

0.37

147

691

Anaemias

732

2015

2.45

96.06

1.1

8.07

7.03

u/ml

0.15

103

357

Gastrointestinal diseases

1459

3937

1.89

94.50

1.1

6.43

3.34

u/ml

1.88

188

639

Any gastric operation

1954

5874

1.69

88.41

1.1

5.86

5.01

u/ml

0.31

226

943

GASTRO-related operations

1954

5874

1.69

88.41

1.1

5.86

5.01

u/ml

0.31

226

943

Noninfective enteritis and colitis

1109

5945

1.90

84.41

1.1

5.27

5.95

u/ml

0.17

102

823

Other specific joint derangements/joint disorders

1813

7110

1.67

83.16

1.1

4.04

5.39

u/ml

0.84

194

1071

Other soft tissue disorders, not elsewhere classified

2101

7768

1.61

80.64

1.1

4.09

5.59

u/ml

0.79

215

1150

Medical observation and evaluation for suspected diseases and conditions

1411

4051

1.81

80.60

1.1

7.61

4.83

u/ml

0.58

142

691

Migraine

1358

6353

1.77

78.72

1.1

3.36

5.63

u/ml

1.88

169

979

Nutritional anaemias

994

5068

1.92

78.49

1.1

8.15

6.81

u/ml

0.34

100

577

Other and unspecified iron deficiency

730

3489

2.14

77.47

1.1

8.81

7.51

u/ml

0.27

423

Other antidepressants

2210

7257

1.58

76.84

1.1

2.71

6.51

u/ml

7.09

245

1004

Diarrhoea and gastroenteritis of presumed infectious origin

2224

9551

1.55

75.94

1.1

5.23

5.62

u/ml

0.14

279

1278

Symptoms and signs involving the circulatory and respiratory systems

2332

7609

1.55

75.33

1.1

5.04

5.33

u/ml

0.10

288

1159

Intestinal infectious diseases

2484

9442

1.52

74.72

1.1

4.83

5.62

u/ml

0.35

311

1252

Inflammatory bowel disease treatment related agents

2519

9419

1.51

73.84

1.1

6.17

5.26

u/ml

0.28

261

1352

Examination and observation for other reasons

1242

4027

1.81

73.67

1.1

6.64

4.86

u/ml

0.52

172

686

Hypothyroidism, strict autoimmune

1581

6338

1.66

71.47

1.1

4.84

3.44

u/ml

0.72

198

846

Iron deficiency anaemia

860

4422

1.95

71.15

1.1

8.70

6.92

u/ml

0.43

514

Osteoporosis

518

2081

2.39

70.61

1.1

15.11

7.72

u/ml

0.67

173

Autoimmune diseases related-to ILD

1842

10120

1.58

70.20

1.1

4.07

5.49

u/ml

0.81

186

1394

Recurrent or chronic depression

968

3635

1.91

70.20

1.1

2.96

5.56

u/ml

2.84

142

555

Diverticular disease of intestine

1211

4401

1.78

69.60

1.1

3.83

7.76

u/ml

3.13

115

571

Behavioural syndromes associated with physiological disturbances and physical factors

2074

9680

1.54

68.69

1.1

5.34

5.46

u/ml

0.03

293

1289

Dermatitis

1278

7565

1.71

68.58

1.1

6.93

5.71

u/ml

0.21

104

995

Depression or dysthymia

1379

4476

1.72

68.57

1.1

4.12

6.59

u/ml

1.48

168

597

Other dorsopathies, not elsewhere classified

2254

7808

1.53

68.33

1.1

5.12

5.49

u/ml

0.14

258

1152

Other noninfective gastroenteritis and colitis

587

2724

2.21

67.50

1.1

4.37

6.98

u/ml

1.06

347

Benign neoplasm of colon, rectum, anus and anal canal

1078

5318

1.79

66.29

1.1

6.37

7.83

u/ml

0.32

558

Other intervertebral disc disorders

1730

6590

1.60

66.04

1.1

4.09

5.75

u/ml

1.31

181

965

Sleep disorders

1981

9480

1.53

64.01

1.1

4.36

5.31

u/ml

0.39

279

1272

Low back pain

1634

7477

1.59

62.65

1.1

7.56

5.56

u/ml

0.62

155

1110

Dorsalgia

2165

7768

1.51

62.41

1.1

5.36

5.49

u/ml

0.04

232

1152

Other headache syndromes

984

5593

1.79

62.03

1.1

2.22

6.52

u/ml

6.54

100

810

Pain (limb, back, neck, head abdominally)

1481

4540

1.65

62.01

1.1

6.70

6.09

u/ml

0.16

180

718

Pain in throat and chest

1824

7135

1.55

61.37

1.1

4.25

5.55

u/ml

1.00

217

1085

Oral corticosteroids

2207

8897

1.49

60.57

1.1

6.36

5.26

u/ml

0.32

232

1274

Abnormalities of breathing

1965

7572

1.52

60.42

1.1

4.89

5.34

u/ml

0.17

204

1152

Insomnia

1954

9528

1.51

60.19

1.1

4.39

5.41

u/ml

0.43

277

1292

Complications of medical and surgical care

1468

8607

1.59

58.50

1.1

5.53

5.71

u/ml

0.05

137

1131

Benign neoplasm: Colon

888

4749

1.81

58.32

1.1

6.21

7.88

u/ml

0.34

472

Hypothyroidism (congenital or acquired)

755

2203

1.98

57.77

1.1

5.29

6.94

u/ml

0.40

109

405

Hypothyroidism and >3 levothyroxin purchases

750

2186

1.98

57.73

1.1

5.19

6.52

u/ml

0.32

112

400

Hypothyroidism, levothyroxine purchases

750

2186

1.98

57.73

1.1

5.19

6.52

u/ml

0.32

112

400

Neurological diseases

1945

6493

1.52

57.54

1.1

4.34

5.63

u/ml

0.81

220

1018

Osteoporosis with pathological fracture (FG)

183

505

3.80

57.48

1.1

51.04

13.53

u/ml

—

Sleep disorders (combined)

2377

8651

1.46

57.34

1.1

4.72

5.50

u/ml

0.30

289

1153

ILD medications

2432

9201

1.45

57.12

1.1

6.51

5.32

u/ml

0.39

259

1317

Hypothyroidism, other/unspecified

1885

8296

1.51

57.02

1.1

4.95

5.61

u/ml

0.25

235

1095

Soft tissue disorders

2234

7886

1.47

56.94

1.1

5.24

5.57

u/ml

0.11

253

1159

Diseases of liver

674

3501

1.96

56.93

1.1

7.85

6.68

u/ml

0.14

445

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1977

9232

1.49

56.86

1.1

8.88

4.97

u/ml

1.61

209

1247

Depression

2086

9671

1.48

56.83

1.1

4.09

5.40

u/ml

0.81

211

1380

Hypothyreosis and Thyroxine purchase for inclusion criteria

1947

8619

1.50

56.52

1.1

5.06

5.58

u/ml

0.19

240

1141

Dorsopathies

2252

7870

1.47

56.42

1.1

5.08

5.51

u/ml

0.16

261

1158

First line medication for Crohn's disease

2380

8989

1.44

55.45

1.1

5.74

5.38

u/ml

0.10

265

1291

Episodal and paroxysmal disorders

2358

8362

1.45

55.08

1.1

3.65

5.95

u/ml

2.47

266

1188

ILD medications: prednisolone, methylprednisolone, prednisone

2292

8928

1.45

54.80

1.1

6.53

5.23

u/ml

0.43

255

1285

Other gastritis (incl. Duodenitis)

406

1764

2.35

54.77

1.1

13.38

7.91

u/ml

0.42

195

Diseases of the skin and subcutaneous tissue

2110

7224

1.48

54.69

1.1

8.51

4.97

u/ml

1.50

254

1032

General symptoms and signs

2322

8090

1.45

54.67

1.1

5.45

5.47

u/ml

0.01

275

1167

Pruritus

301

1145

2.74

54.65

1.1

13.63

4.85

u/ml

0.41

148

Chronic diseases of tonsils and adenoids

1739

7304

1.52

54.09

1.1

6.10

5.90

u/ml

0.05

230

1024

Care involving use of rehabilitation procedures

1308

7617

1.60

53.82

1.1

10.98

5.51

u/ml

1.19

1034

Disorders of the thyroid gland

1962

8717

1.48

53.81

1.1

4.31

5.60

u/ml

0.76

249

1157

Myalgia

562

2808

2.05

53.35

1.1

3.84

6.53

u/ml

1.11

426

Neurotic, stress-related and somatoform disorders

1972

9469

1.47

53.25

1.1

5.18

5.38

u/ml

0.06

220

1365

Pain in limb

1681

7461

1.52

53.17

1.1

5.21

5.42

u/ml

0.06

173

1103

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1185

7282

1.63

52.94

1.1

5.72

6.23

u/ml

0.13

118

924

Other diseases of upper respiratory tract

2219

8043

1.45

52.64

1.1

4.53

6.06

u/ml

0.69

276

1043

Other and unspecified nerve root and plexus disorders, also in other diseases

452

2096

2.21

52.39

1.1

3.31

6.29

u/ml

1.25

302

Follow-up examination after treatment for conditions other than malignant neoplasms

908

3432

1.78

52.36

1.1

9.57

4.82

u/ml

0.87

585

Anxiety disorders

1979

9508

1.47

52.16

1.1

5.16

5.39

u/ml

0.07

221

1367

Other and unspecified dermatitis

1034

6270

1.67

51.56

1.1

6.88

5.94

u/ml

0.12

836

Osteopathies and chondropathies

1083

6172

1.66

51.54

1.1

9.67

6.45

u/ml

0.66

774

Mood [affective] disorders

2163

9833

1.44

51.24

1.1

4.09

5.41

u/ml

0.86

220

1385

Nerve, nerve root and plexus disorders

2104

8975

1.45

51.23

1.1

7.61

4.97

u/ml

0.76

180

1269

Dentofacial anomalies [including malocclusion]

1615

8669

1.52

51.12

1.1

3.62

5.42

u/ml

1.58

219

1265

Haemorrhoids and perianal venous thrombosis

545

2726

2.03

50.87

1.1

3.48

9.59

u/ml

3.10

310

Atopic dermatitis

1396

7426

1.56

50.86

1.1

4.05

5.17

u/ml

0.75

209

1151

Mood disorders

2163

9842

1.44

50.53

1.1

4.09

5.41

u/ml

0.86

220

1385

Anxiety disorders, excluding more controls

1789

7899

1.49

50.52

1.1

5.28

5.42

u/ml

0.04

194

1171

Mood disorders, excluding more controls

1972

8123

1.46

50.25

1.1

4.15

5.30

u/ml

0.65

200

1179

Other joint disorders

2000

7271

1.47

50.01

1.1

4.56

5.50

u/ml

0.35

233

1088

Lower back pain or/and sciatica

2170

10002

1.43

49.76

1.1

6.15

5.13

u/ml

0.38

217

1394

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1102

6851

1.63

49.45

1.1

5.69

6.31

u/ml

0.16

107

857

Chronic gastritis

444

2092

2.16

49.07

1.1

17.43

9.79

u/ml

0.53

206

Budesonide

359

1561

2.37

48.82

1.1

3.12

5.83

u/ml

0.97

224

Malaise and fatigue

980

4759

1.68

48.08

1.1

6.06

6.54

u/ml

0.13

608

Type 1 diabetes, wide definition, subgroup 1

516

2613

2.02

47.16

1.2

1.1

14.94

6.40

u/ml

0.94

418

Selective serotonin reuptake inhibitors

2009

7318

1.45

46.94

1.1

3.00

6.56

u/ml

5.77

252

1013

Collagenous colitis

235

857

2.86

46.44

1.1

1.73

5.55

u/ml

1.55

107

Codeine

2009

7647

1.44

46.42

1.1

4.95

5.28

u/ml

0.11

217

1150

Short Achilles tendon (acquired)

116

272

4.64

46.25

1.1

19.10

6.02

u/ml

—

Dysphagia

425

2025

2.14

45.72

1.1

4.56

8.97

u/ml

0.94

239

Disorders of synovium and tendon

1083

5980

1.61

45.25

1.1

5.58

5.85

u/ml

0.08

112

876

Asthma (mode)

1595

5759

1.50

44.77

1.1

4.94

5.57

u/ml

0.20

191

848

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

995

6011

1.63

44.69

1.1

2.38

6.22

u/ml

6.29

118

836

Codeine or tramadol medication

2319

9187

1.39

44.42

1.1

4.74

5.34

u/ml

0.24

253

1284

Type 1 diabetes, wide definition

523

2724

1.96

44.01

1.2

1.1

14.94

6.56

u/ml

0.92

427

Abnormalities of heart beat

700

3911

1.78

43.83

1.1

4.44

7.09

u/ml

1.12

516

Neurological diseases, wide definition

773

2190

1.80

43.76

1.1

4.08

5.78

u/ml

0.69

105

425

Triptan medication for migraine, single purchase ok

1742

8211

1.45

43.71

1.1

2.83

5.79

u/ml

4.54

253

1157

Migraine, single triptan purchase ok & required. ICD-code if available is included

1742

8211

1.45

43.71

1.1

2.83

5.79

u/ml

4.54

253

1157

Infections, IBD-co-morbidities

333

1015

2.39

43.65

1.1

12.80

6.79

u/ml

0.36

199

Persons encountering health services for examination and investigation

1257

4051

1.57

43.27

1.1

5.11

4.83

u/ml

0.08

142

691

Intestinal infectious diseases

1922

10390

1.42

42.95

1.1

5.42

5.37

u/ml

0.01

206

1421

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

818

2370

1.75

42.64

1.1

4.40

6.40

u/ml

0.72

108

433

Hypothyroidism, strict autoimmune, 3 medication purchases required

1719

8094

1.45

42.58

1.1

4.98

5.47

u/ml

0.18

210

1067

Endocrine, nutritional and metabolic diseases

1830

6469

1.45

42.56

1.1

5.34

5.23

u/ml

0.04

230

1016

Disorders of thyroid, IBD co-morbidities

428

1446

2.12

42.08

1.1

3.68

6.24

u/ml

1.09

272

Other diseases of liver

380

1796

2.17

42.08

1.1

6.59

6.73

u/ml

0.01

226

Asthma

1598

5721

1.48

41.96

1.1

4.98

5.58

u/ml

0.18

189

846

Nausea and vomiting

514

2651

1.93

41.66

1.1

9.61

7.90

u/ml

0.23

362

Type 1 diabetes

568

3099

1.87

41.32

1.1

13.77

6.40

u/ml

0.86

482

Insulin, fast-acting

697

4055

1.75

40.73

1.1

13.85

6.93

u/ml

0.89

560

Parasetamol

1642

5746

1.46

40.40

1.1

5.68

5.24

u/ml

0.12

188

924

Shoulder lesions

1369

5573

1.50

40.11

1.1

2.85

5.95

u/ml

3.47

126

787

Depression medications

796

2340

1.74

40.07

1.1

3.35

6.48

u/ml

2.21

113

427

Asthma, excluding more controls

1558

5587

1.47

39.51

1.1

4.95

5.39

u/ml

0.13

187

837

Sleep apnoea, including avohilmo

1886

8372

1.41

39.38

1.1

4.78

5.74

u/ml

0.42

212

1127

Postmenopausal osteoporosis with pathological fracture

150

467

3.36

39.27

1.2

1.1

51.04

11.63

u/ml

—

Insulin, fast-acting or short human

698

4105

1.73

39.22

1.1

13.85

6.45

u/ml

0.99

554

Dizziness and giddiness

1393

7561

1.47

38.98

1.1

5.06

6.12

u/ml

0.48

130

983

Anxiety (asthma-related co-morbidities)

1397

7408

1.48

38.92

1.1

5.56

5.00

u/ml

0.14

160

1210

Asthma, including avohilmo

2389

9980

1.35

38.90

1.1

5.69

5.35

u/ml

0.10

288

1352

Diaphragmatic hernia

605

3430

1.79

38.78

1.1

9.03

7.48

u/ml

0.25

342

Lumbar disc prolapse

1202

6133

1.52

38.67

1.1

3.94

5.85

u/ml

1.44

144

898

Triptan medication for migraine, min. 3 purchases

1379

7214

1.48

38.49

1.1

2.75

4.96

u/ml

2.64

221

1067

All anxiety disorders

1434

7838

1.46

38.26

1.1

5.49

5.09

u/ml

0.10

164

1242

Chronic sinusitis

840

5219

1.63

38.07

1.1

2.81

6.19

u/ml

2.86

108

739

Arthropathies

1988

7285

1.39

37.88

1.1

3.94

5.51

u/ml

1.17

223

1089

Noninfectious colitis NAS

312

1424

2.25

37.88

1.2

1.1

3.68

5.88

u/ml

0.61

186

Other symptoms and signs involving the digestive system and abdomen

341

1614

2.16

37.60

1.1

3.43

8.37

u/ml

1.73

225

Asthma (only as main-diagnosis)

1439

5721

1.47

37.52

1.1

4.77

5.58

u/ml

0.23

165

846

Symptoms and signs concerning food and fluid intake

230

924

2.56

37.19

1.1

11.20

9.57

u/ml

0.07

103

Fibromyalgia

255

1080

2.45

37.14

1.1

1.48

6.30

u/ml

2.36

176

Heartburn

241

992

2.50

37.13

1.1

3.09

7.94

u/ml

1.30

129

Other and unspecified anaemias

642

3565

1.74

37.00

1.1

11.70

8.07

u/ml

0.43

348

Chronic laryngitis and laryngotracheitis

278

1222

2.33

36.87

1.1

2.82

10.20

u/ml

2.43

140

Special screening examination for infectious and parasitic diseases

624

2632

1.78

36.83

1.1

4.67

4.41

u/ml

0.05

120

535

Symptoms and signs involving cognition, perception, emotional state and behaviour

1859

9193

1.39

36.78

1.1

4.26

5.56

u/ml

0.91

181

1262

Opioids

2061

7838

1.38

36.64

1.1

4.81

5.30

u/ml

0.17

230

1177

Migraine with aura

634

3716

1.74

36.47

1.1

2.98

5.24

u/ml

0.96

586

Other anaemias

644

3594

1.72

36.11

1.1

11.47

7.99

u/ml

0.42

352

Asthma (only as main-diagnosis), excluding more controls

1416

5587

1.46

36.01

1.1

4.77

5.39

u/ml

0.17

165

837

Inflammatory bowel disease

673

4020

1.70

35.95

1.1

5.57

5.71

u/ml

0.02

592

Continuous positive airway pressure

327

1287

2.18

35.95

1.1

5.42

6.93

u/ml

0.31

217

Coxibs

538

1530

1.88

35.48

1.1

2.04

7.78

u/ml

3.76

172

Chronic rhinitis, nasopharyngitis and pharyngitis

646

3829

1.71

35.47

1.1

2.55

6.72

u/ml

3.47

551

Other diseases of anus and rectum

477

2587

1.87

35.15

1.1

6.05

9.50

u/ml

0.65

312

Diseases of the musculoskeletal system and connective tissue

1219

4094

1.51

35.04

1.1

5.08

5.77

u/ml

0.22

156

676

Abnormal weight loss

203

795

2.64

34.90

1.1

12.74

5.52

u/ml

0.36

Other pulmonary diagnosis

1627

5781

1.42

34.68

1.1

6.04

5.53

u/ml

0.13

185

858

General examination and investigation of persons without complaint and reported diagnosis

1164

4050

1.51

34.40

1.1

5.37

4.83

u/ml

0.16

130

691

Other systemic involvement of connective tissue (FG)

492

2686

1.84

34.36

1.1

4.68

7.72

u/ml

1.07

353

Sub-endpoint used in defining T1D endpoints

574

3267

1.76

34.30

1.1

14.02

6.28

u/ml

0.90

460

Cervical disc disorders

609

3586

1.72

34.17

1.1

4.63

7.51

u/ml

1.06

484

Temporomandibular joint disorders, including avohilmo

1041

6873

1.52

34.04

1.1

3.95

5.02

u/ml

0.51

128

1021

Weight loss

218

895

2.52

33.93

1.1

11.19

5.46

u/ml

0.35

Hernia of abdominal wall, postoperative

309

1464

2.15

33.92

1.1

12.97

7.21

u/ml

0.28

216

Acute upper respiratory infections

2035

9338

1.35

33.50

1.1

7.54

5.22

u/ml

0.75

230

1251

Aplastic and other anaemias

683

3875

1.66

33.34

1.1

15.76

8.08

u/ml

0.71

383

Iron deficiency

120

367

3.54

32.96

1.1

1.66

4.28

u/ml

1.01

Disturbances of skin sensation

611

3647

1.71

32.86

1.1

8.59

5.08

u/ml

0.42

530

Systemic connective tissue disorders

639

3864

1.68

32.55

1.1

4.51

7.49

u/ml

1.34

459

Nonalcoholic fatty liver disease

221

933

2.45

32.40

1.1

2.41

5.23

u/ml

1.19

128

Other disorders of urethra and urinary system

1358

6919

1.43

31.98

1.1

5.67

5.96

u/ml

0.08

118

871

Excluding asthma or asthma-COPD overlap

1607

5781

1.40

31.97

1.1

6.09

5.53

u/ml

0.14

183

858

Diseases of the eye and adnexa

1792

6570

1.38

31.83

1.1

4.76

4.88

u/ml

0.05

246

1014

Insulin, intermediate and long-acting

910

5841

1.53

31.49

1.1

12.38

6.60

u/ml

0.85

762

Faecal incontinence

180

699

2.65

31.43

1.1

12.19

11.37

u/ml

0.03

Visual disturbances and blindness

943

6297

1.51

31.15

1.1

5.34

6.73

u/ml

0.49

770

Dyspnoea

1636

8864

1.37

30.81

1.1

4.54

5.88

u/ml

0.65

132

1210

Other bacterial intestinal infections

419

2291

1.86

30.53

1.1

10.45

7.48

u/ml

0.20

271

Abnormal findings on examination of blood, without diagnosis

703

4044

1.61

30.52

1.1

9.09

7.91

u/ml

0.19

464

Dyshidrosis [pompholyx]

158

4.94

30.47

1.2

1.1

3.58

4.51

u/ml

—

Rheumatism, unspecified

278

1323

2.15

30.42

1.1

1.29

9.08

u/ml

2.83

161

Other disorders of lacrimal gland

653

4041

1.64

30.42

1.1

6.89

7.39

u/ml

0.04

504

Pain and other conditions associated with female genital organs and menstrual cycle

528

2838

1.75

30.39

1.1

3.28

4.87

u/ml

0.75

442

Vasomotor and allergic rhinitis

818

5233

1.56

30.37

1.1

3.54

5.87

u/ml

1.86

114

794

Sciatica+with lumbago

933

5738

1.51

30.33

1.1

3.12

5.97

u/ml

2.68

100

838

COPD differential diagnosis

1590

5763

1.39

30.29

1.1

5.83

5.57

u/ml

0.06

183

848

ILD differential diagnosis

1588

5759

1.39

30.15

1.1

5.83

5.57

u/ml

0.06

183

848

Disorders of lacrimal system

779

5023

1.57

30.06

1.1

5.74

7.20

u/ml

0.19

603

Somatoform disorder

364

1922

1.94

29.79

1.1

5.33

6.89

u/ml

0.28

282

IBD patients in KELA-register

493

2856

1.76

29.65

1.1

4.93

5.47

u/ml

0.08

448

Sleep apnoea

1676

8017

1.36

29.45

1.1

4.69

6.02

u/ml

0.74

184

1071

Psychiatric diseases

1901

7132

1.34

29.05

1.1

6.87

5.56

u/ml

0.34

220

1020

Allergic contact dermatitis

320

1635

2.01

28.95

1.1

11.29

5.88

u/ml

0.26

246

Diarrhoea and gastroenteritis of presumed infectious origin

1381

9017

1.39

28.82

1.1

6.65

5.32

u/ml

0.33

148

1261

Complications of surgical and medical care, not elsewhere classified

1840

9494

1.34

28.67

1.1

5.57

5.24

u/ml

0.08

186

1293

Other systemic involvement of connective tissue

502

2949

1.73

28.65

1.1

4.77

8.01

u/ml

1.15

343

Urticaria and erythema

762

4980

1.55

28.12

1.1

6.39

6.14

u/ml

0.04

678

Disorders of skin appendages

994

6847

1.47

28.10

1.1

6.40

5.40

u/ml

0.20

128

968

Other enthesopathies

541

3263

1.68

27.92

1.1

5.80

7.08

u/ml

0.28

500

Complications of procedures, not elsewhere classified

1487

9057

1.37

27.90

1.1

5.25

5.39

u/ml

0.03

156

1227

Falls/tendency to fall

2209

8521

1.31

27.77

1.1

7.10

4.75

u/ml

1.04

246

1245

Acute upper respiratory infections of multiple and unspecified sites

1513

8267

1.37

27.68

1.1

5.84

5.04

u/ml

0.20

162

1196

Asthma, unspecified (mode)

998

5157

1.47

27.66

1.1

5.82

5.95

u/ml

0.02

109

731

Diseases of the ear and mastoid process

2322

9049

1.30

27.54

1.1

5.65

5.05

u/ml

0.23

288

1288

Deviated nasal septum

531

3195

1.68

27.49

1.1

2.32

6.80

u/ml

4.50

445

Asthma, unspecified (mode), excluding more controls

983

5038

1.47

27.47

1.1

5.82

5.73

u/ml

0.02

109

722

Inflammatory bowel disease, strict (require KELA)

493

2923

1.72

27.31

1.1

4.93

5.58

u/ml

0.09

446

Visual disturbances

867

5856

1.50

27.25

1.1

5.39

6.81

u/ml

0.49

738

Procreative management

730

3961

1.56

26.81

1.1

3.58

5.40

u/ml

0.85

605

Symptoms and signs involving the skin and subcutaneous tissue

1299

9252

1.39

26.81

1.1

8.17

5.30

u/ml

0.53

131

1239

Disorders of gallbladder, biliary tract and pancreas

1754

8346

1.33

26.69

1.1

5.47

5.67

u/ml

0.05

189

1107

Disorders of other endocrine glands

849

5640

1.50

26.66

1.1

7.31

6.32

u/ml

0.12

721

ILD medications: immunosuppressive drugs

1203

8031

1.40

26.65

1.1

5.43

5.65

u/ml

0.05

108

1164

Cholecystectomy

1228

7632

1.40

26.49

1.1

3.92

6.31

u/ml

1.19

138

934

Carpal tunnel syndrome

1072

6657

1.43

26.44

1.1

11.26

5.70

u/ml

0.81

910

Other external causes of accidental injury

1657

6194

1.35

26.09

1.1

6.89

4.59

u/ml

0.94

206

916

Tonsillectomy and adenotomy

1345

6836

1.38

26.09

1.1

4.75

4.94

u/ml

0.06

196

1077

Rotator cuff syndrome

968

4785

1.46

26.04

1.1

3.01

6.50

u/ml

3.24

644

Spinal stenosis

691

3377

1.57

25.99

1.1

3.61

8.95

u/ml

2.60

378

Urticaria

647

4161

1.58

25.79

1.1

6.85

5.67

u/ml

0.16

589

5-aminosalicylic acid

442

2585

1.74

25.75

1.1

3.12

5.86

u/ml

1.15

414

Menorrhagia

736

2649

1.56

25.47

1.1

6.07

5.83

u/ml

0.05

366

Excessive, frequent and irregular menstruation

881

3254

1.50

25.42

1.1

5.85

5.20

u/ml

0.16

108

466

Other and unspecified polyneuropathies, also in other diseases

288

1482

1.98

25.38

1.1

20.39

7.98

u/ml

0.45

156

Impingement syndrome of shoulder

386

2182

1.80

25.26

1.1

1.66

8.67

u/ml

4.64

299

Other arrhythmias

1192

6488

1.40

25.08

1.1

5.13

5.38

u/ml

0.08

123

911

Type 1 diabetes, strict (exclude DM2)

261

1305

2.05

25.07

1.1

16.52

4.92

u/ml

0.89

228

Other specified/unspecified arthritis

486

2935

1.68

25.04

1.1

2.99

7.59

u/ml

2.65

432

Type 1 diabetes, definitions combined

261

1307

2.05

24.96

1.1

16.52

5.03

u/ml

0.87

230

Other bacterial intestinal infections

316

1689

1.90

24.88

1.1

10.44

8.51

u/ml

0.08

177

Hypothyroidism, drug reimbursement

335

1264

1.91

24.80

1.1

7.70

8.15

u/ml

0.06

228

Presence of other devices

348

1911

1.84

24.70

1.1

19.90

9.17

u/ml

0.68

162

Persons encountering health services for specific procedures and health care

2094

9800

1.29

24.68

1.1

7.80

4.95

u/ml

1.14

200

1404

Cough

713

4462

1.53

24.63

1.1

4.63

7.21

u/ml

1.01

600

Other/unspecified dorsalgia

670

4349

1.54

24.46

1.1

4.28

6.64

u/ml

0.88

617

Migraine with aura and triptan purchases

408

2376

1.76

24.38

1.1

1.74

5.03

u/ml

3.23

375

Insulin, fast-acting (human)

315

1701

1.89

24.16

1.2

1.1

18.96

5.05

u/ml

0.84

265

Certain infectious and parasitic diseases

1976

7656

1.30

24.15

1.1

6.55

5.34

u/ml

0.39

234

1089

Cholelithiasis

1453

7483

1.35

24.13

1.1

4.63

5.98

u/ml

0.51

145

955

Chronic lower respiratory diseases

2347

9904

1.27

23.95

1.1

5.94

5.26

u/ml

0.22

283

1362

Haemorrhage from respiratory passages

483

2642

1.67

23.95

1.1

10.73

9.87

u/ml

0.05

303

Inflammatory diseases of female pelvic organs

1330

7240

1.36

23.88

1.1

5.04

5.02

u/ml

0.01

152

998

Thyroiditis, ILD-related definition

264

1354

2.00

23.76

1.1

5.73

5.65

u/ml

0.01

190

Acetic acid derivatives and related substances

483

1486

1.71

23.51

1.1

1.93

7.54

u/ml

3.66

168

Polyneuropathies and other disorders of the peripheral nervous system

321

1757

1.86

23.44

1.1

20.39

8.61

u/ml

0.42

180

Benign neoplasm: Colon, unspecified

356

2011

1.80

23.39

1.1

6.32

9.11

u/ml

0.49

188

Genitourinary diseases

1107

3956

1.41

23.21

1.1

4.85

6.05

u/ml

0.43

155

602

2173

8845

1.28

23.16

1.1

7.71

4.86

u/ml

0.98

225

1208

Cholelithiasis, broad definition with cholecystitis

1499

7614

1.33

23.16

1.1

4.65

5.91

u/ml

0.49

150

977

Flat foot [pes planus] (acquired)

189

863

2.25

23.14

1.1

9.28

7.70

u/ml

0.12

121

Accidents

1631

6194

1.33

23.14

1.1

6.89

4.59

u/ml

0.91

199

916

Cervicalgia

363

2071

1.78

23.11

1.1

5.19

7.66

u/ml

0.45

285

Missing teeth due to accident, extraction or parodontitis

896

5918

1.44

22.99

1.1

6.73

7.50

u/ml

0.12

672

Migraine without aura

504

3149

1.63

22.91

1.1

3.72

5.26

u/ml

0.70

509

Disorders of conjunctiva

1641

10130

1.31

22.82

1.1

4.24

5.61

u/ml

0.97

234

1361

Fall on same level

2247

9735

1.27

22.82

1.1

6.91

4.88

u/ml

0.89

247

1390

Insulin, combination of fast acting with intermediate-acting or long-acting

975

6344

1.42

22.81

1.1

11.50

6.27

u/ml

0.81

823

Benign neoplasms

1924

8259

1.29

22.81

1.1

5.72

5.08

u/ml

0.22

267

1172

Ulcerative colitis

471

2895

1.65

22.76

1.1

7.08

6.60

u/ml

0.06

436

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

158

459

2.48

22.75

1.1

16.92

9.90

u/ml

0.41

Other arthritis (FG)

544

3465

1.59

22.59

1.1

2.87

7.93

u/ml

3.59

503

Lichen simplex chronicus and prurigo

133

527

2.61

22.53

1.1

8.78

4.74

u/ml

0.32

Transport accidents

912

5531

1.43

22.47

1.1

3.79

4.31

u/ml

0.23

101

850

Spondylopathies

1267

5586

1.36

22.28

1.1

3.58

6.23

u/ml

2.16

105

788

Diseases of male genital organs

729

2438

1.52

22.24

1.1

5.98

5.39

u/ml

0.16

357

Paralytic ileus and intestinal obstruction

343

1944

1.78

22.19

1.1

1.02

11.48

u/ml

6.34

221

Pain associated with micturition

232

1165

2.04

22.15

1.0

1.1

5.11

5.88

u/ml

0.07

135

Disorders of eyelid, lacrimal system and orbit

1500

8679

1.32

22.12

1.1

4.40

6.09

u/ml

0.53

154

1120

Endometriosis

738

2906

1.51

22.09

1.1

4.52

5.41

u/ml

0.25

412

Candidiasis

564

3647

1.57

22.03

1.1

3.05

6.53

u/ml

2.20

482

Inflammatory diseases of prostate (prostatitis)

170

758

2.28

21.93

1.1

10.46

8.68

u/ml

—

Other diseases of urinary system

1857

8142

1.29

21.83

1.1

4.72

5.73

u/ml

0.34

217

1081

Subjective visual disturbances

460

2842

1.64

21.81

1.1

4.88

6.75

u/ml

0.50

368

Finngen Rheumatological endpoints

1888

8402

1.29

21.75

1.1

3.35

5.59

u/ml

2.80

195

1262

Bacterial intestinal infections, IBD co-morbidities

310

1722

1.83

21.66

1.1

11.32

8.62

u/ml

0.11

183

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

991

6390

1.40

21.57

1.1

3.89

7.27

u/ml

3.03

757

Voice disturbances

469

2922

1.63

21.48

1.1

6.66

6.53

u/ml

0.01

370

Other diseases of the digestive system

431

2626

1.66

21.44

1.1

4.23

5.15

u/ml

0.23

227

Polyuria

330

1872

1.79

21.44

1.1

6.83

8.82

u/ml

0.23

188

Exposure to unspecified factor

1882

10679

1.28

21.16

1.1

7.39

5.06

u/ml

0.76

220

1434

Other extrapyramidal and movement disorders in other diseases

383

2276

1.71

21.11

1.1

2.82

8.30

u/ml

2.59

259

Tramadol

1397

6495

1.33

20.94

1.1

4.42

5.63

u/ml

0.65

122

955

Sicca syndrome [Sjögren]

182

857

2.19

20.78

1.1

6.32

7.07

u/ml

0.08

102

Other arthrosis

815

3931

1.45

20.76

1.1

6.18

6.91

u/ml

0.14

524

Dental operations

997

3660

1.41

20.73

1.1

6.60

5.34

u/ml

0.21

544

Diseases of the respiratory system

1244

4619

1.36

20.68

1.1

7.15

5.40

u/ml

0.43

154

652

Asthma (diagnoses ohter than nonallergic)

1625

10498

1.29

20.63

1.1

4.92

5.35

u/ml

0.13

179

1403

Atopic dermatitis, strict definition with reimbursement

688

4537

1.48

20.63

1.1

4.05

5.03

u/ml

0.39

101

716

Any operation in hilmo

105

177

3.09

20.51

1.1

1.0

8.32

2.52

u/ml

0.47

Cystitis

1601

7369

1.30

20.25

1.1

4.68

5.86

u/ml

0.44

244

949

Barrett oesophagus

308

3.02

20.21

1.2

1.1

16.16

6.06

u/ml

—

Symptoms and signs involving speech and voice

548

3592

1.54

20.11

1.1

6.28

6.94

u/ml

0.07

442

Non-selective monoamine reuptake inhibitors

582

3718

1.52

20.07

1.1

2.06

9.16

u/ml

7.31

455

Bronchitis

2025

10185

1.26

20.04

1.1

5.93

5.17

u/ml

0.23

203

1396

Mycoses

1583

10738

1.29

20.02

1.1

2.58

5.64

u/ml

6.74

200

1440

Type 1 diabetes, strict definition, subgroup 1

214

1085

2.03

19.97

1.1

17.75

4.83

u/ml

0.89

200

Other disorders of skin and subcutaneous tissue

1119

7407

1.35

19.80

1.1

11.05

6.00

u/ml

0.94

900

Type 1 diabetes, strict definition

221

1137

2.00

19.75

1.1

17.55

4.72

u/ml

0.93

205

Other female pelvic inflammatory diseases

329

1916

1.75

19.72

1.1

4.39

6.56

u/ml

0.52

246

Asthma/COPD (KELA code 203)

1819

9878

1.27

19.62

1.1

6.67

5.14

u/ml

0.45

211

1357

Insulin medication

974

5976

1.38

19.61

1.1

11.50

6.25

u/ml

0.82

817

Vocal cord dysfunction

254

1222

1.89

19.57

1.1

1.83

5.98

u/ml

2.20

233

Abnormal serum enzyme levels

374

2194

1.68

19.50

1.1

7.36

7.73

u/ml

0.04

236

Other and unspecified disorders of skin and subcutaneous tissue

131

553

2.44

19.44

1.1

3.24

3.96

u/ml

—

Undetermined asthma, excluding more controls

240

1274

1.92

19.43

1.1

1.19

6.90

u/ml

3.74

180

Ethmoidectomy

248

1334

1.90

19.38

1.1

4.28

5.68

u/ml

0.19

177

Conjunctivitis

1504

9773

1.29

19.36

1.1

3.98

5.57

u/ml

1.21

220

1324

Undetermined asthma

240

1277

1.91

19.29

1.1

1.19

7.67

u/ml

4.00

181

Fenamates

264

962

1.89

19.18

1.1

1.16

8.20

u/ml

3.95

123

Neuromuscular dysfunction of bladder

164

765

2.19

19.13

1.1

1.36

5.97

u/ml

—

Other symptoms and signs involving the circulatory and respiratory systems

134

577

2.38

18.97

1.1

6.25

6.39

u/ml

—

Fissure and fistula of anal and rectal regions

375

2280

1.66

18.95

1.1

3.39

8.23

u/ml

2.34

319

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

353

2120

1.69

18.84

1.1

2.57

6.72

u/ml

2.12

313

Acute sinusitis

1033

7107

1.36

18.80

1.1

8.86

5.01

u/ml

0.71

119

1084

Other disorders of patella

348

2086

1.70

18.71

1.1

3.58

6.73

u/ml

1.40

364

Noninflammatory disorders of female genital tract

922

3327

1.41

18.69

1.1

4.69

5.26

u/ml

0.14

119

474

Asthma-related infections

1041

7597

1.35

18.68

1.1

6.99

5.84

u/ml

0.20

998

Asthma, hospital admission 2, infections

1041

7597

1.35

18.68

1.1

6.99

5.84

u/ml

0.20

998

Symptoms and signs involving the urinary system

1213

7006

1.33

18.65

1.1

4.65

6.55

u/ml

0.75

898

FESS (DNB20)

240

1294

1.89

18.65

1.1

4.28

5.71

u/ml

0.19

176

Sensorineural hearing loss

1091

5515

1.35

18.61

1.1

8.36

7.24

u/ml

0.20

646

Cardiovascular diseases

1448

6007

1.31

18.55

1.1

5.96

4.66

u/ml

0.53

179

1004

Other nutritional deficiencies

1253

9036

1.32

18.50

1.1

4.29

5.44

u/ml

0.63

147

1300

Generalized anxiety disorder

389

2411

1.64

18.43

1.1

3.67

4.90

u/ml

0.39

391

Bullous disorders

113

457

2.55

18.42

1.2

1.1

38.09

6.02

u/ml

0.90

Ulcerative colitis (strict definition, all Crohn cases excluded)

287

1643

1.78

18.29

1.1

1.73

5.46

u/ml

3.12

251

Other specified/unspecified systemic involvement of connective tissue

129

557

2.39

18.27

1.1

6.59

4.34

u/ml

0.32

Other symptoms and signs involving cognitive functions and awareness

638

3993

1.47

18.24

1.1

3.10

8.15

u/ml

3.03

445

Pollen allergy

451

2864

1.58

18.22

1.1

3.55

5.32

u/ml

0.82

431

Fibroblastic disorders

320

1888

1.71

18.13

1.1

17.97

8.90

u/ml

0.46

240

Allergic rhinitis

688

4772

1.44

18.04

1.1

3.93

5.53

u/ml

0.84

706

Polyarthrosis

296

1585

1.76

18.03

1.1

3.35

10.27

u/ml

2.18

166

Caries of dentine

367

2186

1.65

18.01

1.1

11.71

7.34

u/ml

0.28

350

Deforming dorsopathies

479

3127

1.55

17.97

1.1

3.71

7.19

u/ml

1.46

425

Other diseases of hard tissues of teeth

958

3612

1.38

17.87

1.1

9.10

6.67

u/ml

0.36

100

517

Endometriosis of pelvic peritoneum

360

2099

1.66

17.84

1.1

3.20

5.51

u/ml

1.11

320

Dental caries

409

2477

1.61

17.82

1.1

11.26

6.87

u/ml

0.32

396

Striking against or struck by other objects

623

4296

1.47

17.81

1.1

3.06

6.50

u/ml

2.67

616

Any mental disorder

2032

8211

1.25

17.67

1.1

6.64

5.45

u/ml

0.33

217

1184

Antihypertensive medication - note that there are other indications

1420

5831

1.30

17.67

1.1

5.62

4.81

u/ml

0.31

190

950

Other diseases of lip and oral mucosa

681

4789

1.44

17.58

1.1

3.90

6.86

u/ml

1.26

620

Use of hypnotics and sedatives

1896

8748

1.25

17.56

1.1

3.94

5.72

u/ml

1.21

199

1229

830

5989

1.39

17.53

1.1

3.80

6.11

u/ml

1.17

830

Nonorganic sleeping disorders, excluding more controls

399

2517

1.61

17.52

1.1

3.38

5.17

u/ml

0.78

407

Ulcerative colitis (strict definition, require KELA)

326

1957

1.69

17.48

1.1

2.78

5.86

u/ml

1.36

290

Implicit bacterial Sepsis

535

3174

1.51

17.44

1.1

9.70

8.41

u/ml

0.12

311

Allergic asthma (mode)

503

3274

1.52

17.32

1.1

6.88

5.33

u/ml

0.19

540

Concussion

929

5602

1.36

17.26

1.1

4.96

5.77

u/ml

0.27

101

880

Other and unspecified urticaria

396

2504

1.61

17.25

1.1

7.41

6.17

u/ml

0.10

351

Allergic asthma (mode), excluding more controls

503

3278

1.52

17.21

1.1

6.88

5.20

u/ml

0.21

540

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

316

1890

1.70

17.20

1.1

2.78

5.73

u/ml

1.27

277

Other anxiety disorders

994

6449

1.35

17.18

1.1

3.71

5.01

u/ml

0.77

104

1026

External causes of morbidity and mortality

1313

5053

1.31

17.17

1.1

7.62

4.79

u/ml

0.96

163

780

Enthesopathies of lower limb, excluding foot

383

2403

1.61

17.15

1.1

5.19

7.20

u/ml

0.38

353

Intestinal malabsorption

103

414

2.58

17.10

1.2

1.1

16.58

4.01

u/ml

0.59

KRA_PSY_EATING, excluding more controls

244

1360

1.83

16.94

1.1

4.79

3.85

u/ml

0.26

232

Implicit viral Sepsis

313

1876

1.69

16.82

1.1

6.78

7.79

u/ml

0.13

210

Benign neoplasm: Ascending colon

204

1079

1.92

16.81

1.1

9.12

8.19

u/ml

0.05

Diabetic retinopathy, strict definition

265

1334

1.78

16.81

1.1

28.93

3.38

u/ml

1.11

120

Viral Sepsis

314

1884

1.69

16.81

1.1

6.78

7.79

u/ml

0.13

210

Diseases of oral cavity, salivary glands and jaws

956

3623

1.37

16.68

1.1

6.63

6.67

u/ml

0.01

517

Other diseases of intestine

196

1025

1.94

16.66

1.1

3.58

10.58

u/ml

1.32

117

Disease of hard tissues of teeth, NOS

925

3551

1.37

16.66

1.1

6.92

6.68

u/ml

0.04

109

514

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

601

4180

1.45

16.55

1.1

5.88

6.97

u/ml

0.20

550

Persons encountering health services in other circumstances

762

5494

1.39

16.53

1.1

8.32

5.96

u/ml

0.33

770

Factors influencing health status and contact with health services

504

1655

1.54

16.49

1.1

6.71

5.57

u/ml

0.20

298

Syncope and collapse

690

4194

1.42

16.47

1.1

4.40

7.53

u/ml

1.18

503

Extrapyramidal and movement disorders

532

3617

1.48

16.42

1.1

4.46

8.22

u/ml

1.45

394

Irregular menses

1068

6416

1.33

16.39

1.1

5.23

4.62

u/ml

0.14

142

962

Obesity related asthma

573

3962

1.46

16.27

1.1

4.33

6.51

u/ml

0.60

560

Ovarian cyst

739

3040

1.42

16.24

1.1

7.01

5.31

u/ml

0.38

431

Vitamin B12 deficiency anaemia

153

741

2.10

16.19

1.1

11.15

7.73

u/ml

0.24

Atopic dermatitis, strict definition

668

4658

1.42

16.18

1.1

4.08

5.46

u/ml

0.58

100

707

Fracture of lumbar spine and pelvis

313

1892

1.67

16.17

1.1

14.25

8.04

u/ml

0.36

176

Asthma, hospital admissions , main diagnosis only

1505

10584

1.26

16.05

1.1

4.84

5.48

u/ml

0.19

170

1421

Conductive and sensorineural hearing loss

1165

6041

1.31

16.02

1.1

7.45

6.87

u/ml

0.11

741

Other disorders of skin and subcutaneous tissue, not elsewhere classified

236

1328

1.81

15.98

1.1

7.14

6.63

u/ml

0.05

151

GI-bleeding

404

2608

1.56

15.93

1.1

4.04

4.98

u/ml

0.23

228

Hyperkinetic disorders, excluding more controls

313

1826

1.67

15.87

1.1

4.51

4.17

u/ml

0.06

311

Implicit Sepsis

1182

6891

1.30

15.85

1.1

6.37

6.45

u/ml

0.02

874

Pain in thoracic spine

275

1622

1.72

15.78

1.1

4.18

7.16

u/ml

0.74

243

Recurrent aphthous stomatitis , including avohilmo

269

1579

1.73

15.77

1.1

4.84

6.76

u/ml

0.41

193

Exposure to other specified factors

1388

10092

1.27

15.75

1.1

5.52

5.37

u/ml

0.04

173

1390

Hyperplasia of prostate

370

1307

1.62

15.43

1.1

6.81

7.46

u/ml

0.09

161

Cervicobrachial syndrome

374

2396

1.58

15.38

1.1

5.73

7.31

u/ml

0.32

359

Abnormal findings on diagnostic imaging of lung

613

4151

1.43

15.31

1.1

5.36

9.11

u/ml

1.74

405

Caries of enamel

1671

9749

1.24

15.30

1.1

3.17

5.71

u/ml

4.01

231

1354

Crohn disease

252

1466

1.75

15.28

1.1

8.78

4.56

u/ml

0.37

222

Other enthesopathy of foot (+metatarsalgia)

188

1003

1.91

15.19

1.1

3.20

6.90

u/ml

0.70

135

Any reimbursement code in KELA

1317

5162

1.29

15.14

1.1

6.48

4.70

u/ml

0.62

145

915

Cardiac arrhythmias

1195

6037

1.30

15.08

1.1

4.65

5.22

u/ml

0.21

146

982

Paracetamol or NSAID medication

341

1048

1.66

15.04

1.1

6.54

9.62

u/ml

0.47

135

Other diseases of stomach and duodenum

104

445

2.39

15.01

1.1

30.61

6.75

u/ml

—

Other neurological diseases

1063

6420

1.31

15.01

1.1

5.66

6.93

u/ml

0.33

765

Soft tissue disorders related to use, overuse and pressure

403

2641

1.54

14.95

1.1

4.03

8.13

u/ml

1.63

360

False labour

733

3317

1.40

14.92

1.1

4.45

u/ml

0.00

594

Disorders of vestibular function (Vertigo)

699

4998

1.39

14.87

1.1

7.47

7.48

u/ml

0.00

569

Crohn's disease of small intestine

149

741

2.06

14.87

1.0

1.1

3.66

3.69

u/ml

0.00

109

COPD/asthma related infections

1950

7999

1.23

14.85

1.1

9.27

4.84

u/ml

1.51

216

1131

COPD/asthma/ILD related infections

1950

7999

1.23

14.85

1.1

9.27

4.84

u/ml

1.51

216

1131

Diseases of inner ear

804

5778

1.36

14.82

1.1

6.83

7.07

u/ml

0.04

669

Diseases of tongue

117

530

2.26

14.82

1.1

2.01

6.28

u/ml

1.42

Pure hypercholesterolaemia

1073

5383

1.31

14.72

1.1

7.04

6.72

u/ml

0.06

669

Migraine without aura and triptan purchases

386

2522

1.56

14.71

1.1

2.17

5.17

u/ml

2.90

401

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1097

8291

1.30

14.69

1.1

4.44

5.53

u/ml

0.55

175

1146

Glomerular disorders in diseases classified elsewhere

182

973

1.90

14.61

1.1

22.66

7.88

u/ml

0.62

114

Polyarthropathies

1149

5831

1.29

14.57

1.1

4.04

5.79

u/ml

1.03

108

854

Abnormal findings on antenatal screening of mother

243

1425

1.75

14.53

1.1

6.26

2.56

u/ml

0.68

246

Enterocolitis due to Clostridium difficile

163

843

1.97

14.44

1.1

28.11

8.03

u/ml

—

Oxicams

331

1159

1.64

14.42

1.1

6.23

7.70

u/ml

0.25

132

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

412

2.44

14.42

1.1

28.51

3.04

u/ml

—

Second line medication for Crohn's disease

1003

7728

1.31

14.41

1.1

5.88

6.06

u/ml

0.03

1066

Oedema, not elsewhere classified

472

3176

1.48

14.38

1.1

13.08

7.74

u/ml

0.37

392

Benign neoplasm of other and ill-defined parts of digestive system

270

1626

1.68

14.37

1.1

7.93

7.39

u/ml

0.04

167

Symptoms and signs involving the nervous and musculoskeletal systems

945

7228

1.32

14.31

1.1

7.19

6.16

u/ml

0.13

932

Bacterial Sepsis

611

3723

1.41

14.30

1.1

8.47

7.58

u/ml

0.11

400

Other disorders of ear

1498

7886

1.25

14.26

1.1

6.42

5.88

u/ml

0.15

146

1038

Unspecified urinary incontinence

158

814

1.98

14.23

1.1

5.89

6.84

u/ml

—

Injuries to the knee and lower leg

2200

10186

1.20

14.17

1.1

7.00

5.11

u/ml

0.81

265

1368

Thyrotoxicosis, other and/or unspecified

355

2294

1.57

14.14

1.1

4.77

6.13

u/ml

0.32

299

Ganglion

379

2486

1.54

14.09

1.1

4.26

5.93

u/ml

0.57

396

Polycystic ovarian syndrome, consortium definition

1494

7119

1.25

14.07

1.1

5.76

4.93

u/ml

0.21

166

991

Mixed connective tissue disease

131

635

2.12

14.06

1.1

4.49

u/ml

0.00

Mycoses

424

2849

1.51

14.03

1.1

4.12

7.13

u/ml

1.41

361

Other disorders of glucose regulation and pancreatic internal secretion

154

792

1.99

13.95

1.2

1.1

23.24

5.09

u/ml

0.59

103

Propionic acid derivatives

491

1668

1.49

13.93

1.1

3.30

8.00

u/ml

1.92

189

Type1 diabetes, definitions combined, early onset

177

953

1.90

13.91

1.1

19.41

5.30

u/ml

0.68

159

Polycystic ovarian syndrome

169

903

1.93

13.86

1.1

1.71

4.45

u/ml

1.53

156

Dipeptidyl peptidase 4 (DPP-4) inhibitors

724

4269

1.37

13.83

1.1

4.89

8.25

u/ml

1.22

470

Restless leg syndrome

229

1336

1.74

13.79

1.1

2.16

5.26

u/ml

1.77

148

Ulcerative colitis, NAS

256

1539

1.69

13.79

1.1

9.37

5.60

u/ml

0.34

231

Other disorders of fluid, electrolyte and acid-base balance

412

2627

1.51

13.72

1.1

22.39

9.46

u/ml

0.38

259

Allergic conjunctivitis

1134

8706

1.28

13.70

1.1

4.37

5.45

u/ml

0.56

179

1192

Stomatitis and related lesions

346

2243

1.56

13.62

1.1

3.78

7.05

u/ml

1.21

276

Bacterial pneumonia, not elsewhere classified

570

3573

1.42

13.59

1.1

12.50

7.05

u/ml

0.61

425

Other sleep disorders

189

1048

1.83

13.54

1.1

2.33

6.55

u/ml

1.87

145

Nonorganic sleeping disorders

399

2671

1.51

13.54

1.1

3.38

6.01

u/ml

1.20

384

Viral and other specified intestinal infections

592

4110

1.40

13.51

1.1

2.11

5.79

u/ml

4.65

611

Reimbursement for rheumatic diseases

953

7332

1.30

13.47

1.1

3.79

6.31

u/ml

1.48

952

Papulosquamous disorders

608

4402

1.39

13.40

1.1

6.17

6.86

u/ml

0.12

577

Pain, not elsewhere classified

479

3328

1.45

13.36

1.1

7.30

6.88

u/ml

0.03

478

Psychotic depression

115

541

2.17

13.29

1.1

2.52

6.06

u/ml

0.97

Gastroduodenal ulcer

281

1736

1.63

13.29

1.1

5.93

8.74

u/ml

0.50

170

Injuries to the abdomen, lower back, lumbar spine and pelvis

617

4433

1.39

13.29

1.1

6.88

6.34

u/ml

0.09

534

Diseases of salivary glands

538

3824

1.42

13.26

1.1

2.41

6.80

u/ml

3.87

509

Infections of the skin and subcutaneous tissue

1015

7856

1.29

13.12

1.1

6.55

5.70

u/ml

0.15

107

1110

Fever of other and unknown origin

923

6330

1.31

13.12

1.1

3.69

6.07

u/ml

2.03

876

Sequelae of injuries of upper limb

174

954

1.86

13.00

1.1

8.83

5.91

u/ml

0.28

131

Injuries to the ankle and foot

1349

9683

1.25

13.00

1.1

5.36

5.25

u/ml

0.03

170

1417

Persons encountering health services in circumstances related to reproduction

1075

5672

1.29

12.97

1.1

6.91

5.36

u/ml

0.35

156

856

Postprocedural disorders of nervous system

171

936

1.87

12.94

1.1

3.17

4.29

u/ml

0.19

149

Spondylosis

732

4450

1.35

12.94

1.1

3.65

7.22

u/ml

2.26

577

Oter anti-inflammatory and antirheumatic agents, non-steroids

271

900

1.68

12.92

1.1

4.60

8.47

u/ml

1.09

Metatarsalgia

170

927

1.87

12.91

1.1

3.56

7.42

u/ml

0.63

122

Eating disorders

269

1668

1.64

12.90

1.1

4.73

4.48

u/ml

0.06

248

Benign neoplasm: Stomach

152

800

1.94

12.88

1.1

11.72

6.63

u/ml

0.26

Presence of cardiac and vascular implants and grafts

501

2604

1.44

12.85

1.1

12.79

9.37

u/ml

0.30

231

Hypoglycaemia, other or unspecified

128

636

2.06

12.84

1.2

1.1

26.75

4.61

u/ml

0.62

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

167

909

1.87

12.79

1.1

1.86

5.16

u/ml

—

114

Arthrosis

1136

4904

1.28

12.72

1.1

5.48

6.02

u/ml

0.15

124

706

Crohn disease (strict definition, all UC cases excluded)

115

553

2.14

12.68

1.0

1.1

3.04

3.85

u/ml

0.13

Female infertility, cervical, vaginal, other or unspecified origin

579

2704

1.41

12.67

1.1

2.47

4.84

u/ml

2.12

412

Eating disorder

244

1485

1.68

12.65

1.1

4.79

4.80

u/ml

0.00

225

Erosion of teeth , including avohilmo

484

3413

1.44

12.56

1.1

2.46

5.49

u/ml

2.50

491

Condition for Implicit Sepsis (Organ dysfunction codes)

1401

8021

1.24

12.52

1.1

5.60

5.72

u/ml

0.03

101

1081

Ovarian dysfunction

204

1194

1.75

12.36

1.1

2.16

4.40

u/ml

1.30

205

Post-traumatic stress disorder

216

1284

1.72

12.31

1.1

6.26

4.59

u/ml

0.28

215

Arthropathies in other diseases classified elsewhere

287

2.59

12.27

1.1

16.25

4.17

u/ml

—

Sequelae of injuries, of poisoning and of other consequences of external causes

382

2587

1.49

12.25

1.1

12.18

6.45

u/ml

0.44

367

Convalescence

110

527

2.14

12.23

1.1

6.76

5.41

u/ml

—

Other maternal disorders predominantly related to pregnancy

1178

5892

1.26

12.17

1.1

6.73

4.46

u/ml

0.62

158

875

Asthma and allergy

293

1855

1.58

12.15

1.1

4.22

5.43

u/ml

0.23

300

Acute gastritis

113

547

2.10

12.14

1.1

5.49

5.69

u/ml

—

Candidiasis

242

1486

1.65

12.08

1.1

5.57

6.20

u/ml

0.11

187

Intestinal stricture

400

2745

1.47

11.94

1.1

1.22

9.30

u/ml

6.29

289

Bacterial pneumonia (organism specified)

625

4191

1.36

11.92

1.1

11.82

6.80

u/ml

0.59

488

L04AX Other immunosuppressants

948

7443

1.28

11.87

1.1

4.53

6.23

u/ml

0.64

1013

Fracture of rib(s), sternum and thoracic spine

391

2675

1.47

11.87

1.1

2.77

7.37

u/ml

2.88

303

Metabolic disorders

1567

7879

1.22

11.78

1.1

6.80

5.52

u/ml

0.31

149

1093

Asthma and allergy, excluding more controls

293

1869

1.57

11.78

1.1

4.22

5.42

u/ml

0.23

306

Fall on same level involving ice and snow

937

7356

1.28

11.78

1.1

6.82

6.19

u/ml

0.14

945

Other diseases of oesophagus

130

669

1.97

11.77

1.2

1.1

13.67

6.41

u/ml

—

Lateral epicondylitis

224

1360

1.67

11.68

1.1

10.05

8.79

u/ml

0.11

211

Abnormal findings on diagnostic imaging of other body structures

214

1286

1.69

11.62

1.1

2.80

7.96

u/ml

1.63

141

Disorders of ocular muscles, binocular movement, accommodation and refraction

867

6696

1.29

11.61

1.1

7.03

5.52

u/ml

0.27

108

932

Other retinal disorders

862

5203

1.30

11.59

1.1

15.53

7.06

u/ml

1.13

567

Neoplasms

1578

6894

1.22

11.58

1.1

5.59

5.11

u/ml

0.15

227

1015

Viral infections characterized by skin and mucous membrane lesions

1524

10780

1.21

11.56

1.1

5.20

5.30

u/ml

0.04

199

1418

Renal failure

528

3375

1.39

11.55

1.1

22.42

8.87

u/ml

1.00

315

Anti-inflammatory and antirheumatic products, non-steroids

475

1669

1.44

11.45

1.1

3.50

8.00

u/ml

1.73

189

Bacterial pneumoniae

591

3843

1.37

11.45

1.1

12.05

6.71

u/ml

0.63

459

Tongue abnormality

109

534

2.09

11.44

1.1

2.93

6.11

u/ml

—

Female infertility

623

2796

1.37

11.34

1.1

2.30

4.77

u/ml

2.39

425

Other bullous disorders

228

2.73

11.34

1.3

1.1

49.17

4.42

u/ml

0.93

Radiculopathy

213

1286

1.67

11.31

1.1

5.15

7.66

u/ml

0.29

146

Spondylolisthesis/Spondylolysis

266

1697

1.59

11.30

1.1

2.87

7.66

u/ml

1.63

224

Rosacea

206

1241

1.69

11.14

1.1

10.25

4.89

u/ml

0.32

146

Other or unspecified ileus, impaction or obstruction

213

1290

1.67

11.14

1.1

1.02

10.33

u/ml

4.05

135

Injuries to the thorax

638

4795

1.34

11.08

1.1

4.97

7.05

u/ml

0.68

612

Other eating disorders

146

802

1.87

11.04

1.1

5.83

5.39

u/ml

0.07

128

Disorders of vitreous body and globe

691

5050

1.32

10.98

1.1

9.35

7.98

u/ml

0.14

525

Other shoulder lesions

167

954

1.78

10.95

1.1

1.70

5.32

u/ml

1.79

135

Chronic pancreatitis

164

932

1.78

10.90

1.1

3.49

7.39

u/ml

0.92

109

Adenomyosis (Endometriosis of uterus)

231

1441

1.63

10.86

1.1

5.45

6.08

u/ml

0.07

186

Other hearing loss

313

2041

1.51

10.82

1.1

6.12

9.63

u/ml

0.45

175

Hyperkinetic disorders

316

2077

1.52

10.76

1.1

4.51

4.37

u/ml

0.03

322

Gastric ulcer

196

1174

1.69

10.73

1.1

5.17

9.82

u/ml

0.67

106

Hernia

1553

8666

1.21

10.71

1.1

8.18

5.29

u/ml

0.78

177

1151

Injuries to the neck

403

2835

1.44

10.68

1.1

4.96

6.45

u/ml

0.31

410

Plantar fascial fibromatosis

165

948

1.77

10.62

1.1

9.11

9.22

u/ml

—

127

Leisure time condition

300

1998

1.52

10.55

1.1

3.74

6.81

u/ml

0.84

248

Disorders of vitreous body

669

4926

1.32

10.53

1.1

9.36

8.09

u/ml

0.12

509

Follow-up care involving plastic surgery

392

2.24

10.52

1.1

4.47

6.28

u/ml

—

Diabetic maculopathy, excluding more controls

173

1010

1.74

10.51

1.2

1.1

13.94

4.17

u/ml

—

132

Other/unspecified enthesopathies of lower limb, excluding foot

128

684

1.91

10.48

1.1

7.37

6.09

u/ml

0.09

102

Glaucoma suspect

470

3405

1.39

10.44

1.1

4.35

9.41

u/ml

1.01

322

Nummular dermatitis

125

664

1.92

10.40

1.1

9.93

4.27

u/ml

0.89

Lichen ruber planus, wide definition including periferal and oral lichen planus

322

2182

1.49

10.39

1.1

7.61

7.53

u/ml

0.01

244

Panic disorder

321

2178

1.49

10.37

1.1

4.70

4.40

u/ml

0.07

353

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

140

774

1.85

10.34

1.1

9.59

3.55

u/ml

0.38

115

Complications of internal orthopaedic prosthetic devices, implants and grafts

279

1836

1.53

10.34

1.1

13.20

9.16

u/ml

0.26

169

Atypical facial pain

487

2.08

10.34

1.1

5.57

5.26

u/ml

0.03

Chronic kidney disease

335

2245

1.47

10.26

1.1

25.48

8.86

u/ml

0.76

189

Secondary hypertension

121

631

1.92

10.22

1.2

1.1

7.61

7.11

u/ml

—

Obesity due to excess calories

839

6623

1.28

10.20

1.1

4.05

5.42

u/ml

0.66

959

Kyphosis

3.61

10.20

1.1

—

9.07

—

Diseases of external ear

507

3736

1.37

10.16

1.1

12.03

7.54

u/ml

0.39

478

Covid-19 confirmed case

540

4018

1.35

10.15

1.1

6.41

6.90

u/ml

0.09

488

Intracranial trauma

1017

5740

1.25

10.14

1.1

5.19

5.65

u/ml

0.14

113

906

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1982

9189

1.18

10.03

1.1

5.44

5.42

u/ml

0.01

243

1248

Any death

471

4592

0.73

9.96

1.1

23.84

7.93

u/ml

0.82

447

Postmenopausal atrophic vaginitis

399

1539

1.44

9.94

1.1

4.22

8.24

u/ml

1.17

176

Excessive vomiting in pregnancy

185

1121

1.69

9.92

1.1

0.94

3.34

u/ml

3.93

184

Crohn disease (strict definition, require KELA, min 2 HDR)

129

705

1.87

9.91

1.1

10.73

3.46

u/ml

0.41

107

Use of pramipexole

296

1993

1.50

9.87

1.1

12.53

8.49

u/ml

0.23

201

Internal derangement of knee

579

4351

1.33

9.84

1.1

2.89

6.44

u/ml

2.68

654

Hyperhidrosis

319

2.33

9.84

1.0

1.1

1.62

5.69

u/ml

—

Herpesviral [herpes simplex] infections

463

3386

1.38

9.82

1.1

3.06

6.07

u/ml

1.69

478

Blepharochalasis

380

2685

1.43

9.82

1.1

2.78

10.82

u/ml

3.69

244

Crohn disease (strict definition, require KELA)

130

715

1.86

9.79

1.1

10.73

3.46

u/ml

0.41

107

Disturbance of activity and attention

299

1989

1.50

9.70

1.1

4.17

3.89

u/ml

0.05

305

Other symptoms and signs involving the nervous and musculoskeletal systems

676

5227

1.30

9.69

1.1

3.97

6.04

u/ml

0.81

708

Congenital malformations, deformations and chromosomal abnormalities

1219

9275

1.22

9.67

1.1

4.49

5.25

u/ml

0.30

158

1368

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

113

2037

0.54

9.65

1.1

3.55

9.21

u/ml

—

182

Thyrotoxicosis

414

2981

1.40

9.64

1.1

5.16

6.26

u/ml

0.29

375

Cervicocranial syndrome

169

1005

1.71

9.64

1.1

4.88

6.84

u/ml

0.21

138

Use of memantine

255

1376

1.55

9.64

1.1

8.30

17.15

u/ml

—

Use of other anti-dementia drugs

255

1376

1.55

9.64

1.1

8.30

17.15

u/ml

—

Other metabolic disorders

239

1549

1.56

9.62

1.1

4.01

6.07

u/ml

0.52

204

Acne

246

1608

1.55

9.52

1.1

4.90

4.28

u/ml

0.14

249

Unspecified fall

773

6002

1.28

9.51

1.1

5.91

7.07

u/ml

0.27

754

Viral and other specified intestinal infections

434

3083

1.39

9.48

1.1

2.35

4.91

u/ml

2.62

443

Thyrotoxicosis with diffuse goitre

255

1682

1.54

9.48

1.1

5.53

6.77

u/ml

0.23

225

All influenza

379

2695

1.42

9.46

1.1

10.03

5.89

u/ml

0.70

335

Dislocation, sprain and strain of joints and ligaments at neck level

284

1918

1.50

9.43

1.1

4.23

5.58

u/ml

0.25

292

Benign neoplasm: Rectum

229

1475

1.57

9.43

1.1

7.20

10.01

u/ml

0.28

136

Unspecified/other endometriosis

215

1371

1.60

9.37

1.1

1.26

5.55

u/ml

3.03

229

Disorders of muscles

162

961

1.71

9.34

1.1

21.00

5.74

u/ml

0.56

131

Trochanteric bursitis

208

1314

1.60

9.33

1.1

5.92

8.80

u/ml

0.42

155

Benign neoplasm: Sigmoid colon

236

1534

1.55

9.33

1.1

1.63

9.74

u/ml

3.22

145

Postprocedural endocrine and metabolic disorders, not elsewhere classified

222

1426

1.58

9.32

1.1

4.16

5.99

u/ml

0.41

188

Gonarthrosis

921

4191

1.26

9.30

1.1

4.38

6.60

u/ml

1.11

565

Diseases of middle ear and mastoid

1098

7362

1.23

9.28

1.1

6.41

4.92

u/ml

0.37

153

1065

Fibrosis and cirrhosis of liver

112

597

1.91

9.28

1.1

3.90

4.32

u/ml

—

Benign neoplasm: Transverse colon

139

792

1.78

9.26

1.1

7.20

6.99

u/ml

—

Endometriosis ASRM stages 1,2

366

2606

1.42

9.21

1.1

3.20

5.41

u/ml

1.01

397

Sudden idiopathic hearing loss

140

801

1.77

9.20

1.1

2.78

5.49

u/ml

—

Lichen planus

191

1188

1.63

9.18

1.1

8.57

8.62

u/ml

0.00

113

Transient ischemic attack

626

3899

1.31

9.05

1.1

6.06

9.36

u/ml

0.63

347

Intestinal adhesions without obstruction

111

595

1.89

9.02

1.0

1.1

0.76

9.22

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

251

1666

1.52

9.02

1.1

6.97

9.64

u/ml

0.28

154

Mouth breathing

580

4435

1.32

9.01

1.1

6.40

6.51

u/ml

0.02

616

Abrasion of teeth

541

4105

1.33

9.00

1.1

5.41

5.95

u/ml

0.08

552

Drug-induced osteoporosis with pathological fracture

129

3.08

8.94

1.0

1.1

—

8.54

—

Personality disorders, excluding more controls

491

3680

1.35

8.90

1.1

3.42

4.81

u/ml

0.54

633

Dislocation, sprain and strain of joints and ligaments of knee

1082

8212

1.22

8.87

1.1

5.06

5.07

u/ml

0.00

151

1201

Percutaneous Coronary Intervention

1112

5595

1.22

8.86

1.1

10.62

6.46

u/ml

0.81

707

Gout

268

1585

1.50

8.86

1.1

10.76

9.65

u/ml

0.08

171

Achilles tendinitis

152

900

1.71

8.85

1.1

4.54

7.91

u/ml

0.56

123

Skin changes due to chronic exposure to nonionizing radiation

404

2704

1.39

8.84

1.1

16.89

10.38

u/ml

0.52

156

Disorders of parathyroid gland

275

1845

1.49

8.82

1.1

24.40

9.06

u/ml

0.49

170

Other inflammatory liver diseases

106

565

1.91

8.82

1.1

5.25

5.16

u/ml

—

Exclusions for E4_PCOS_BROAD

290

1992

1.47

8.81

1.1

3.97

6.89

u/ml

0.74

265

Malignant neoplasm of bronchus and lung, including Hilmo

1345

0.51

8.79

1.1

33.40

11.38

u/ml

—

Iron deficiency anaemia secondary to blood loss (chronic)

214

1381

1.57

8.77

1.1

6.30

8.12

u/ml

0.15

148

Other skin changes

252

1685

1.51

8.77

1.1

1.65

8.19

u/ml

3.24

174

Persons encountering health services in other circumstances, wide

2067

9205

1.16

8.73

1.1

4.89

5.42

u/ml

0.26

251

1248

Autoimmune hyperthyroidism

118

654

1.84

8.71

1.1

3.85

3.27

u/ml

0.09

Malignant neoplasm of respiratory system and intrathoracic organs

1311

0.50

8.71

1.1

33.43

10.50

u/ml

—

Other disorders of bone

328

2312

1.43

8.70

1.1

2.71

6.72

u/ml

1.70

326

Cellulitis

331

2337

1.43

8.68

1.1

3.43

7.20

u/ml

1.61

313

Crushed, pushed or stepped on by crowd or human stampede

145

855

1.73

8.64

1.1

10.66

5.07

u/ml

0.71

125

Female genital prolapse

472

1971

1.36

8.62

1.1

11.39

6.25

u/ml

0.51

258

Lactose intolerance

299

2.27

8.60

1.2

1.1

3.64

5.81

u/ml

0.37

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

177

1098

1.63

8.59

1.1

6.67

7.40

u/ml

0.06

128

Diabetic nephropathy

199

1253

1.59

8.59

1.1

24.41

5.42

u/ml

0.87

Bacterial infection, other or unspecified

705

4820

1.28

8.58

1.1

9.95

7.11

u/ml

0.28

530

Other disorders of eyelid

553

4028

1.31

8.57

1.1

2.50

9.00

u/ml

5.14

395

437

2960

1.36

8.56

1.1

14.59

10.96

u/ml

0.30

193

Unspecified haematuria

489

3041

1.34

8.54

1.1

6.99

8.01

u/ml

0.15

344

Dermatitis herpetiformis

149

2.87

8.54

1.4

1.1

54.01

5.99

u/ml

—

Heart failure, not strict

987

5467

1.23

8.53

1.1

15.10

6.73

u/ml

1.03

658

Redundant prepuce, phimosis and paraphimosis

264

1773

1.49

8.53

1.1

5.69

5.87

u/ml

0.03

283

Other disorders of kidney and ureter

174

1079

1.63

8.49

1.1

30.71

7.54

u/ml

0.79

115

Other heart diseases, wide

1663

8693

1.17

8.47

1.1

6.93

5.16

u/ml

0.52

198

1262

Emergency coronary revascularization (for ACS)

1167

5879

1.21

8.46

1.1

10.34

6.37

u/ml

0.79

100

725

Rheumatoid arthritis

451

3010

1.35

8.44

1.1

3.47

7.63

u/ml

2.40

413

Coronary revascularization (ANGIO or CABG)

1108

5596

1.22

8.43

1.1

10.52

6.46

u/ml

0.79

707

Other reaction to severe stress, and adjustment disorders

710

5632

1.27

8.42

1.1

3.61

4.82

u/ml

0.59

910

Anankastic personality disorder

457

2.00

8.38

1.0

1.1

2.59

4.17

u/ml

—

Other and unspecified rosacea

146

870

1.71

8.37

1.1

13.95

5.47

u/ml

0.37

111

Other inflammation of eyelid

211

1374

1.56

8.37

1.1

2.78

7.57

u/ml

1.37

163

Hypertension, essential

1294

6133

1.20

8.32

1.1

7.77

5.20

u/ml

0.71

152

896

Disorders of mineral metabolism

125

714

1.78

8.32

1.1

4.27

6.60

u/ml

—

Other follicular disorders

138

812

1.73

8.31

1.1

1.53

3.75

u/ml

1.23

114

Contraceptive management

749

4175

1.27

8.31

1.1

7.80

5.09

u/ml

0.48

675

Dental pulpitis, including avohilmo

1701

9480

1.17

8.29

1.1

5.64

5.01

u/ml

0.19

202

1401

Ventral hernia

311

2191

1.43

8.27

1.1

13.58

7.74

u/ml

0.29

252

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

781

3962

1.26

8.27

1.1

3.68

3.61

u/ml

0.02

107

675

Other/unspecified synovitis and tenosynovitis

176

1103

1.62

8.24

1.1

7.54

7.57

u/ml

0.00

147

Glomerular diseases

246

1660

1.50

8.22

1.1

17.68

6.16

u/ml

0.65

201

Infections with a predominantly sexual mode of transmission

619

4841

1.29

8.19

1.1

6.06

4.98

u/ml

0.15

753

Malignant neoplasm of bronchus and lung

1113

0.48

8.17

1.1

38.90

9.03

u/ml

—

Other disorders of the musculoskeletal system and connective tissue

210

1374

1.55

8.15

1.1

12.45

9.01

u/ml

0.17

150

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

517

3957

1.32

8.15

1.1

3.95

5.65

u/ml

0.66

596

Colonic or urogenital fistula

390

2863

1.37

8.14

1.1

3.35

6.99

u/ml

1.89

363

Sequelae of external causes of morbidity and mortality

352

2543

1.40

8.11

1.1

5.31

7.79

u/ml

0.52

299

Major coronary heart disease event

1169

5873

1.21

8.10

1.1

9.48

6.37

u/ml

0.60

105

737

Cholangitis (primary sclerosing, PSC)

489

1.94

8.09

1.2

1.1

6.06

6.52

u/ml

—

Mucosal proctocolitis

216

1425

1.54

8.09

1.1

1.48

5.26

u/ml

3.08

229

Gonarthrosis [arthrosis of knee](FG)

1072

5143

1.22

8.09

1.1

4.58

6.95

u/ml

1.29

107

702

Coxarthrosis

624

3208

1.29

8.07

1.1

4.53

7.92

u/ml

1.51

413

Excessive attrition of teeth

988

8158

1.22

8.06

1.1

2.41

5.54

u/ml

5.42

127

1179

Other general symptoms and signs

101

542

1.88

8.04

1.1

4.33

5.19

u/ml

0.15

Disorders of tooth development and eruption

302

1715

1.44

8.03

1.1

8.20

5.84

u/ml

0.22

301

Inflammatory disease of uterus

289

2026

1.45

8.01

1.1

5.24

5.73

u/ml

0.08

311

Dermatographic urticaria

132

776

1.74

8.01

1.1

8.78

3.86

u/ml

0.55

113

Fracture of femur

296

1880

1.44

8.00

1.1

22.68

9.35

u/ml

—

152

Coxarthrosis [arthrosis of hip](FG)

683

3793

1.27

8.00

1.1

5.26

8.89

u/ml

1.44

474

Acute renal failure

243

1645

1.49

7.98

1.1

16.43

7.95

u/ml

—

143

Ulcerative proctitis

114

644

1.80

7.94

1.1

1.13

3.86

u/ml

—

Benign neoplasm: Caecum

135

799

1.71

7.93

1.1

7.82

8.68

u/ml

0.07

Congenital malformations, deformations and chromosomal abnormalities

1102

8768

1.20

7.87

1.1

4.93

5.25

u/ml

0.09

130

1315

Hallux valgus (acquired)

493

2691

1.33

7.86

1.1

10.57

8.14

u/ml

0.17

357

Lichen planus, including avohilmo

265

1834

1.46

7.82

1.1

8.34

7.04

u/ml

0.14

193

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

107

595

1.83

7.82

1.1

25.06

8.25

u/ml

—

Other viral diseases

711

5651

1.26

7.78

1.1

5.58

5.53

u/ml

0.01

115

816

Nasal polyp

243

1655

1.48

7.77

1.1

2.04

9.53

u/ml

4.49

212

Benzodiazepine use

1719

10229

1.16

7.76

1.1

2.91

5.57

u/ml

4.29

165

1424

Carbimazole or st.post thyroidectomy, condition for graves disease

351

2559

1.39

7.72

1.1

6.83

6.07

u/ml

0.10

331

Acne vulgaris

194

1268

1.56

7.69

1.1

5.50

4.12

u/ml

0.26

190

Appendectomy

1151

9252

1.20

7.68

1.1

6.70

5.14

u/ml

0.37

128

1347

Palmar fascial fibromatosis [Dupuytren]

154

950

1.63

7.67

1.1

27.81

9.70

u/ml

—

Tinnitus

321

2308

1.40

7.65

1.1

4.01

7.75

u/ml

1.18

296

Injury, poisoning and certain other consequences of external causes

1041

4312

1.22

7.60

1.1

5.20

5.08

u/ml

0.03

141

657

Oxycodone

457

3133

1.33

7.59

1.1

8.02

7.95

u/ml

0.01

383

Brachial plexus disorders

168

1065

1.60

7.58

1.1

4.41

6.03

u/ml

0.21

181

Obesity and other hyperalimentation

1096

8853

1.20

7.57

1.1

4.07

5.42

u/ml

0.73

126

1279

Hypertensive diseases (excluding secondary)

970

4640

1.22

7.57

1.1

8.26

4.93

u/ml

0.80

124

766

Neuralgia and neuritis, unspecified

452

1.94

7.55

1.1

1.57

4.47

u/ml

—

Seborrhoeic dermatitis

133

796

1.69

7.52

1.1

19.37

3.95

u/ml

0.40

101

SLE (Finngen)

303

2.17

7.52

1.1

0.78

4.14

u/ml

—

Phobic anxiety disorders

279

1964

1.44

7.52

1.2

1.1

11.34

5.52

u/ml

0.51

323

Obsessive-compulsive disorder

153

952

1.64

7.50

1.1

9.75

4.54

u/ml

0.53

157

Other obstetric conditions, not elsewhere classified

784

4034

1.25

7.47

1.1

3.79

3.96

u/ml

0.05

109

688

Abnormal results of function studies

138

837

1.67

7.44

1.1

2.16

4.72

u/ml

—

110

Hypertension

1338

6417

1.18

7.33

1.1

7.37

5.24

u/ml

0.57

157

944

Viral infections characterized by skin and mucous membrane lesions

651

5195

1.26

7.32

1.1

6.77

6.23

u/ml

0.12

704

Special screening examination for other diseases and disorders

157

986

1.61

7.31

1.1

4.65

6.06

u/ml

0.19

152

therapeutic use

210

2.39

7.30

1.1

6.53

5.72

u/ml

—

Postmenopausal bleeding

370

1441

1.38

7.29

1.1

4.43

8.29

u/ml

1.03

154

Other disorders of penis

111

637

1.76

7.29

1.1

6.74

6.92

u/ml

—

All chronic kidney diseases

733

4838

1.24

7.27

1.1

14.45

6.91

u/ml

1.07

571

Sequelae with surgical and medical care as external cause

272

1919

1.43

7.26

1.1

6.65

8.35

u/ml

0.24

205

Hypertensive diseases

1338

6424

1.18

7.26

1.1

7.37

5.25

u/ml

0.57

157

946

Bipolar affective disorders

344

2529

1.37

7.22

1.1

3.07

5.14

u/ml

0.96

410

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

146

906

1.63

7.20

1.1

5.63

4.42

u/ml

0.13

108

Polyp of the female genital tract

515

2279

1.31

7.18

1.1

3.82

5.87

u/ml

0.61

316

Fitting and adjustment of other devices

413

2810

1.33

7.17

1.1

8.31

9.53

u/ml

0.14

261

Endometriosis of ovary

302

2123

1.40

7.15

1.1

2.76

5.91

u/ml

1.92

310

Diseases of pulp and periapical tissues and dental caries

1067

4558

1.20

7.13

1.1

9.58

5.61

u/ml

0.81

110

644

Diseases of appendix

1264

9715

1.18

7.12

1.1

6.45

5.20

u/ml

0.32

147

1376

Bacterial infection, other or unspecified

772

5315

1.23

7.10

1.1

8.59

6.75

u/ml

0.21

621

Obesity

1086

8832

1.19

7.10

1.1

4.07

5.42

u/ml

0.73

126

1277

Abnormal involuntary movements

199

1330

1.51

7.07

1.1

6.29

7.77

u/ml

0.20

161

Disorders of choroid and retina

1109

6632

1.19

7.07

1.1

11.98

6.30

u/ml

1.14

801

Other respiratory diseases principally affecting the interstitium

199

1329

1.51

7.05

1.1

15.03

7.31

u/ml

0.58

107

Other disorders of eye and adnexa

236

1635

1.46

7.01

1.1

4.20

6.55

u/ml

0.59

222

Asthma-related pneumonia

480

3706

1.30

7.01

1.1

13.03

7.58

u/ml

0.52

434

Injuries to the hip and thigh

614

4427

1.26

7.00

1.1

11.21

7.69

u/ml

0.37

493

Orchitis and epididymitis

101

571

1.79

7.00

1.0

1.1

6.54

7.39

u/ml

—

Charcot foot

142

2.70

6.99

1.1

17.30

2.66

u/ml

—

Acute appendicitis, no complications

959

7973

1.20

6.98

1.1

6.27

4.88

u/ml

0.28

108

1204

Other/unspecified enthesopathies, not elsewhere classified

120

714

1.70

6.97

1.1

2.77

8.63

u/ml

1.24

Dental caries, including avohilmo

1172

5056

1.19

6.92

1.1

9.18

5.42

u/ml

0.80

115

707

Bleeding

1172

7062

1.18

6.92

1.1

6.81

6.49

u/ml

0.05

100

877

Diabetic nephropathy, excluding more controls

195

1067

1.52

6.90

1.1

24.41

3.86

u/ml

0.97

Anomalies of dental arch relationship, including avohilmo

373

2517

1.35

6.90

1.1

3.13

6.17

u/ml

1.65

341

Asthma-related pneumonia or sepsis

480

3715

1.30

6.89

1.1

13.03

7.56

u/ml

0.52

435

Asthma, hospital admissions 3, pneumonia

480

3715

1.30

6.89

1.1

13.03

7.56

u/ml

0.52

435

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

333

2457

1.37

6.88

1.1

9.54

5.32

u/ml

0.30

358

Hypopituitarism

114

672

1.72

6.88

1.1

5.62

7.00

u/ml

—

103

Enlarged lymph nodes

229

1583

1.46

6.85

1.1

3.01

8.09

u/ml

2.10

212

Glaucoma

674

4675

1.25

6.84

1.1

4.22

9.06

u/ml

1.37

444

Fracture of shoulder and upper arm

507

3960

1.29

6.83

1.1

4.51

7.56

u/ml

1.48

468

Adverse effects, not elsewhere classified

345

2562

1.36

6.82

1.1

4.32

6.09

u/ml

0.60

351

Appendicitis, broad definition

1251

9679

1.17

6.80

1.1

6.48

5.20

u/ml

0.33

146

1376

Other specified/unspecified bacterial intestinal infections

563

1.79

6.79

1.1

2.91

6.25

u/ml

—

Diabetic maculopathy

166

1013

1.56

6.78

1.2

1.1

15.29

4.00

u/ml

—

Angina pectoris

662

3541

1.25

6.75

1.1

14.54

8.20

u/ml

0.62

352

Actinic keratosis

373

2591

1.34

6.73

1.1

16.02

11.14

u/ml

0.34

141

Other bursopathies

165

1071

1.56

6.72

1.1

2.12

7.70

u/ml

1.95

127

Hard cardiovascular diseases

1226

6221

1.18

6.70

1.1

8.22

5.78

u/ml

0.48

112

827

Disorders of continuity of bone

161

1042

1.57

6.69

1.1

13.65

4.82

u/ml

0.62

143

Memory loss

108

632

1.73

6.68

1.2

1.1

5.61

11.54

u/ml

0.60

Ischemic heart diseases

1171

5965

1.18

6.67

1.1

9.59

6.15

u/ml

0.74

112

768

Other and unspecified follicular disorders

373

1.97

6.67

1.1

2.04

5.36

u/ml

0.78

Malignant neoplasm of breast

469

3928

0.77

6.66

1.1

3.89

6.67

u/ml

1.30

478

243

1711

1.44

6.64

1.1

6.46

5.31

u/ml

0.20

245

Hernia of abdominal wall

609

4887

1.25

6.62

1.1

11.08

6.57

u/ml

0.46

626

Type of accident

449

3477

1.30

6.58

1.1

6.20

6.59

u/ml

0.06

459

Other disorders of bladder

138

864

1.61

6.57

1.1

27.25

6.64

u/ml

0.48

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

470

3257

1.30

6.55

1.1

4.49

4.13

u/ml

0.09

508

Persistent mood disorders

300

2197

1.38

6.49

1.1

5.51

7.14

u/ml

0.31

290

Ménière disease

130

806

1.63

6.48

1.1

5.60

6.57

u/ml

—

Primary hyperparathyroidism

156

1011

1.56

6.45

1.1

14.62

9.30

u/ml

—

Lichen simplex chronicus

275

2.12

6.43

1.1

11.04

4.10

u/ml

—

ILD, hospital admission 2, with pulmonary infections

110

654

1.70

6.42

1.1

26.04

9.03

u/ml

—

Malignant neoplasm of breast, HER2-negative

462

3868

0.78

6.40

1.1

3.89

6.72

u/ml

1.32

472

Acute appendicitis

1173

9383

1.17

6.40

1.1

6.66

5.13

u/ml

0.39

138

1355

Disorders of lipoprotein metabolism and other lipidaemias

1147

6040

1.18

6.39

1.1

5.92

6.13

u/ml

0.05

109

803

Certain disorders involving the immune mechanism

268

1932

1.40

6.39

1.1

8.95

7.28

u/ml

0.17

242

Intussusception

173

2.44

6.39

1.1

0.72

9.76

u/ml

—

Other contact dermatitis

133

834

1.62

6.35

1.1

1.35

4.61

u/ml

2.03

123

Benign neoplasm of other and unspecified endocrine glands

187

1264

1.50

6.34

1.1

12.33

4.91

u/ml

0.53

137

Graves disease, strict definition

182

1225

1.51

6.34

1.1

5.30

4.73

u/ml

0.10

171

Injuries to the wrist and hand

1737

10571

1.14

6.33

1.1

4.61

5.51

u/ml

0.49

191

1444

Raynaud syndrome

151

977

1.57

6.33

1.1

4.52

3.96

u/ml

0.07

139

STROKE

787

4409

1.22

6.32

1.1

6.13

6.41

u/ml

0.05

606

Spondyloarthritis

258

1851

1.41

6.31

1.1

4.76

7.08

u/ml

0.43

268

Other and unspecified effects of external causes

486

3826

1.28

6.29

1.1

5.82

5.63

u/ml

0.04

548

Diabetes medication

1780

9279

1.14

6.28

1.1

6.56

5.42

u/ml

0.31

154

1345

Other superficial mycoses

185

1252

1.50

6.27

1.1

3.31

4.64

u/ml

0.33

183

Caries of dentine, including avohilmo

1274

5578

1.17

6.26

1.1

9.18

5.23

u/ml

0.98

130

784

Disorders of refraction and accommodation

470

3673

1.28

6.26

1.1

10.87

6.23

u/ml

0.53

523

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

810

4229

1.22

6.24

1.1

4.31

4.97

u/ml

0.23

107

690

Hypo-osmolality and hyponatraemia

204

1398

1.46

6.24

1.2

1.1

9.69

11.84

u/ml

—

128

Other ulcerative colitis

579

1.74

6.21

1.1

1.69

3.81

u/ml

—

Otitis externa

334

2505

1.34

6.21

1.1

15.52

6.86

u/ml

0.61

330

Tooth eruption problems

321

2337

1.35

6.19

1.1

5.08

4.20

u/ml

0.24

337

Adhesive capsulitis of shoulder

212

1475

1.45

6.18

1.1

4.69

8.44

u/ml

0.65

185

Sulfasalazine

428

3323

1.30

6.17

1.1

3.21

5.88

u/ml

1.20

500

Spondylopathies (FG)

219

1535

1.44

6.16

1.1

3.38

7.25

u/ml

1.26

246

Diseases of arteries, arterioles and capillaries (FINNGEN)

309

1573

1.37

6.16

1.1

19.38

7.57

u/ml

0.52

227

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1645

9392

1.14

6.13

1.1

6.43

5.24

u/ml

0.34

176

1298

Trigger finger

198

1364

1.47

6.10

1.1

2.29

8.14

u/ml

2.34

189

Primary gonarthrosis, bilateral

605

4187

1.24

6.08

1.1

4.02

9.16

u/ml

2.41

431

Gingivitis and periodontal diseases

1738

7878

1.14

6.08

1.1

6.68

5.64

u/ml

0.27

213

1061

Glucosamine medication

539

3428

1.26

6.07

1.1

4.93

10.70

u/ml

2.11

262

Intracranial injury

913

7274

1.19

6.07

1.1

5.52

6.25

u/ml

0.20

941

Anorexia (incl.atypical)

132

839

1.60

6.01

1.1

4.74

5.20

u/ml

0.09

129

Other complications of surgical and medical care, not elsewhere classified

155

1021

1.54

5.99

1.1

0.63

4.80

u/ml

—

130

Other predominantly sexually transmitted diseases, not elsewhere classified

343

2600

1.33

5.98

1.1

4.13

4.91

u/ml

0.20

410

Family history of malignant neoplasm

200

1388

1.46

5.98

1.1

2.75

5.93

u/ml

1.03

195

Deficiency of other B group vitamins

166

2.42

5.98

1.1

13.27

6.12

u/ml

—

1512

7994

1.15

5.94

1.1

8.24

4.84

u/ml

1.23

144

1131

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1512

7994

1.15

5.94

1.1

8.24

4.84

u/ml

1.23

144

1131

Specific personality disorders

441

3458

1.29

5.94

1.1

3.37

5.21

u/ml

0.78

535

Moderate visual impairment, binocular

204

2.25

5.94

1.1

—

21.94

—

Chondropathies

243

1748

1.40

5.92

1.1

3.19

5.98

u/ml

0.81

247

Monoamine oxidase A inhibitors

155

1023

1.53

5.92

1.1

1.00

9.01

u/ml

2.74

122

Other noninflammatory disorders of uterus, except cervix

299

1484

1.37

5.92

1.1

6.18

8.02

u/ml

0.25

170

Benign paroxysmal vertigo

386

2975

1.31

5.91

1.1

8.85

7.74

u/ml

0.14

340

Infective dermatitis

157

1040

1.53

5.90

1.1

1.88

7.73

u/ml

—

130

ILD, hospital admissions 1, main diag only

150

984

1.54

5.88

1.1

19.85

8.74

u/ml

0.65

Other CVD (FINNGEN)

131

640

1.60

5.88

1.1

6.72

9.09

u/ml

—

Other menopausal disorders

431

1881

1.30

5.85

1.1

1.99

6.25

u/ml

3.04

253

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

449

1.81

5.82

1.2

1.1

5.99

4.50

u/ml

—

Ankylosing hyperostosis [Forestier]

3.01

5.81

1.0

1.1

—

8.40

—

Atrial fibrillation and flutter with reimbursement

320

1517

1.35

5.81

1.1

8.37

7.62

u/ml

0.07

208

Other noninflammatory disorders of vulva and perineum

168

1136

1.50

5.76

1.1

8.96

6.58

u/ml

0.19

170

Other acute lower respiratory infections

802

6398

1.20

5.75

1.1

5.49

6.03

u/ml

0.16

833

Malignant neoplasm of breast, ER-positive, including Hilmo

323

3280

0.75

5.74

1.1

1.81

7.66

u/ml

5.14

378

Congenital malformations and deformations of the musculoskeletal system

211

1483

1.43

5.73

1.1

3.67

4.76

u/ml

0.35

224

Cardiovascular diseases (excluding rheumatic etc)

1331

6643

1.16

5.72

1.1

6.65

4.67

u/ml

0.66

176

1086

Thyroiditis

122

771

1.61

5.71

1.1

0.79

4.47

u/ml

2.34

Artrosis, including avohilmo

1326

6293

1.16

5.69

1.1

4.37

5.69

u/ml

0.61

151

901

Unspecified acute lower respiratory infection

212

1500

1.43

5.69

1.1

5.44

6.59

u/ml

0.17

213

Zoster [herpes zoster]

668

5420

1.22

5.68

1.1

6.62

7.57

u/ml

0.23

599

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

401

3126

1.29

5.66

1.1

3.54

7.37

u/ml

1.55

461

Glucagon-like peptide-1 (GLP-1) analogues

401

3126

1.29

5.66

1.1

3.54

7.37

u/ml

1.55

461

Injuries to the elbow and forearm

1173

8912

1.16

5.66

1.1

9.78

5.53

u/ml

1.15

120

1188

Osteomyelitis

482

1.77

5.65

1.1

3.58

6.31

u/ml

—

Infections with a predominantly sexual mode of transmission

806

6304

1.20

5.64

1.1

4.68

4.67

u/ml

0.00

121

974

Hydrocele

109

670

1.64

5.64

1.1

6.29

8.68

u/ml

—

Car occupant injured in other and unspecified transport accidents

316

2388

1.33

5.64

1.1

3.47

5.82

u/ml

0.74

347

Varicose veins

832

5273

1.20

5.64

1.1

6.58

7.56

u/ml

0.22

615

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1537

8128

1.14

5.63

1.1

7.46

5.77

u/ml

0.39

124

1153

Scoliosis

150

996

1.53

5.63

1.1

4.39

5.87

u/ml

0.23

143

ILD, hospital admissions

162

1091

1.50

5.63

1.1

18.28

8.22

u/ml

0.63

Diabetes, insulin treatment (Kela reimbursement)

1602

8519

1.14

5.61

1.1

7.85

5.71

u/ml

0.54

126

1186

Other interstitial pulmonary diseases

164

1108

1.49

5.61

1.1

18.28

8.05

u/ml

0.64

Diabetes mellitus

1770

9165

1.13

5.60

1.1

6.38

5.39

u/ml

0.27

161

1337

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

132

853

1.57

5.60

1.1

2.82

6.20

u/ml

1.18

136

Nonsuppurative otitis media

458

3140

1.27

5.59

1.1

7.02

4.12

u/ml

0.65

438

Vitreous haemorrhage

132

853

1.57

5.58

1.2

1.1

33.51

6.03

u/ml

—

Recurrent dislocation and subluxation of joint

118

744

1.61

5.57

1.1

2.45

5.19

u/ml

1.25

124

Bruxism

211

2.21

5.56

1.1

2.62

6.38

u/ml

—

Bicipital tendinitis

368

1.88

5.56

1.1

1.07

3.47

u/ml

—

Interstitial lung disease endpoints

164

1110

1.49

5.56

1.1

18.28

8.05

u/ml

0.64

Interstitial lung disease

164

1110

1.49

5.56

1.1

18.28

8.05

u/ml

0.64

Seronegative rheumatoid arthritis

154

1030

1.51

5.55

1.1

3.96

9.36

u/ml

—

119

Radial styloid tenosynovitis [de Quervain]

599

1.68

5.53

1.0

1.1

13.56

5.15

u/ml

—

Immunodeficiencies

464

1.78

5.53

1.2

1.1

22.89

5.81

u/ml

—

Agoraphobia

399

1.85

5.52

1.2

1.1

8.09

6.81

u/ml

—

Trigeminal neuralgia

531

1.72

5.51

1.1

9.78

5.42

u/ml

—

6-mercaptopurine

370

1.88

5.51

1.2

1.1

23.42

5.24

u/ml

—

Benign neoplasm: Adrenal gland

103

630

1.66

5.50

1.1

18.21

3.85

u/ml

0.55

Elevated blood glucose level

117

739

1.60

5.48

1.1

11.18

5.53

u/ml

—

Bulimia nervosa (incl. atypical)

519

1.74

5.48

1.1

3.32

5.13

u/ml

0.42

Other and unspecified visual disturbances

151

1010

1.51

5.47

1.1

6.12

5.77

u/ml

0.05

125

Crowding of teeth, including avohilmo

208

1219

1.43

5.47

1.1

1.58

6.49

u/ml

2.41

164

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

189

1321

1.45

5.46

1.1

10.99

6.32

u/ml

0.42

154

Varicose veins of other sites

555

1.70

5.46

1.1

5.04

5.32

u/ml

0.03

Struck by thrown, projected or falling objec

488

1.75

5.45

1.1

4.21

4.99

u/ml

—

Stenosis and insufficiency of lacrimal passages

136

891

1.54

5.43

1.2

1.1

1.48

7.16

u/ml

2.32

Disorders of sclera, cornea, iris and ciliary body

846

7162

1.19

5.42

1.1

3.46

6.12

u/ml

2.29

102

978

Other hammer toe(s) (acquired)

205

1339

1.42

5.42

1.1

24.89

9.72

u/ml

0.43

129

Other (seronegative) rheumatoid arthritis, wide

250

1835

1.37

5.41

1.1

3.96

7.52

u/ml

1.13

191

Other abnormal uterine and vaginal bleeding

353

1940

1.31

5.39

1.1

5.13

6.55

u/ml

0.17

256

Malignant neoplasm of breast, HER-positive

319

3249

0.76

5.39

1.1

1.81

7.72

u/ml

5.17

375

Diabetic neuropathy

128

824

1.56

5.38

1.1

44.27

5.97

u/ml

—

Other strabismus

369

2857

1.30

5.38

1.1

2.32

6.92

u/ml

3.49

401

Benign lipomatous neoplasm

387

3024

1.29

5.38

1.1

5.58

7.44

u/ml

0.35

364

Injuries to the shoulder and upper arm

1287

9055

1.15

5.33

1.1

4.81

5.95

u/ml

0.65

136

1166

Organic, including symptomatic, mental disorders

517

2961

1.25

5.32

1.1

20.29

10.79

u/ml

0.26

221

Diabetes mellitus in pregnancy

726

3873

1.21

5.31

1.1

5.56

3.63

u/ml

0.35

688

Ulcer of lower limb, not elsewhere classified

155

1049

1.49

5.28

1.1

32.65

6.83

u/ml

0.67

Colectomy operation

199

1414

1.42

5.24

1.1

15.79

9.82

u/ml

0.23

138

Cerebral cysts

585

1.67

5.24

1.1

3.37

3.50

u/ml

—

Other specified/unspecified inflammatory spondylopathies

502

1.72

5.23

1.1

4.58

5.02

u/ml

—

Systemic lupus erythematosus

348

1.88

5.22

1.1

0.78

5.43

u/ml

—

Phlebitis and thrombophlebitis (not including DVT)

296

2248

1.33

5.12

1.1

2.80

8.31

u/ml

2.06

280

Premenstrual syndrome

141

2.44

5.11

1.1

3.38

5.63

u/ml

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

474

3819

1.25

5.11

1.1

6.05

6.84

u/ml

0.14

513

Coagulation defects, purpura and other haemorrhagic conditions

278

2095

1.34

5.10

1.1

1.85

7.25

u/ml

3.56

259

Diabetic retinopathy, excluding more controls

340

1459

1.32

5.09

1.1

22.32

3.91

u/ml

1.22

124

Diabetes, varying definitions

1750

9141

1.13

5.08

1.1

6.30

5.41

u/ml

0.24

163

1329

Polymyalgia rheumatica

139

928

1.51

5.08

1.1

7.49

8.96

u/ml

—

Cluster headache, wide

380

1.82

5.08

1.0

1.1

2.14

4.22

u/ml

—

Acute pancreatitis

228

1667

1.38

5.07

1.1

5.32

8.28

u/ml

0.48

198

Hypermetropia

116

746

1.58

5.06

1.1

4.24

8.88

u/ml

0.73

106

Senile cataract

722

3694

1.20

5.06

1.1

10.07

7.58

u/ml

0.52

424

Azathioprine

231

1695

1.37

5.06

1.1

7.76

6.14

u/ml

0.20

260

Childhood asthma (age<16)

293

1749

1.33

5.05

1.1

4.11

4.67

u/ml

0.10

312

Pedal cyclist injured in transport accident

343

2665

1.30

5.04

1.1

5.34

6.34

u/ml

0.17

377

Nail disorders

126

827

1.54

5.03

1.1

2.76

4.75

u/ml

—

110

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1475

8342

1.14

5.01

1.1

4.60

5.67

u/ml

0.52

160

1106

Disorders of lens

834

4410

1.18

4.99

1.1

10.44

6.85

u/ml

0.96

562

Other necrotizing vasculopathies (FG)

448

1.74

4.99

1.1

0.78

8.82

u/ml

—

Other abnormal auditory perceptions

106

2.65

4.98

1.1

1.55

12.29

u/ml

—

Haemangioma, any site

128

845

1.53

4.98

1.0

1.1

5.00

5.09

u/ml

0.01

111

Psoriasis

394

3118

1.27

4.98

1.1

2.32

6.82

u/ml

3.52

422

Childhood asthma (age<16), excluding more controls

293

1752

1.33

4.98

1.1

4.11

4.59

u/ml

0.08

313

Herpesviral [herpes simplex] infections

181

1279

1.43

4.98

1.0

1.1

5.12

4.44

u/ml

0.10

170

Diabetic retinopathy

394

1928

1.28

4.97

1.1

22.32

4.20

u/ml

1.19

158

Other and unspecified tonsillitis

645

4513

1.21

4.97

1.1

2.86

4.56

u/ml

1.53

773

Calcific aortic valvular stenosis, including rheumatic fever

267

1942

1.34

4.96

1.1

15.94

9.96

u/ml

0.26

114

Calcific aortic valvular stenosis, diagnosis (helper)

266

1936

1.34

4.95

1.1

15.94

9.96

u/ml

0.26

114

Operations 2 for CAVS

266

1936

1.34

4.95

1.1

15.94

9.96

u/ml

0.26

114

Lactose intolerance, other/unspecified

269

1.98

4.95

1.2

1.1

3.96

6.42

u/ml

—

Haemangioma and lymphangioma, any site

138

928

1.51

4.93

1.0

1.1

4.92

4.84

u/ml

0.01

122

268

1752

1.34

4.92

1.1

26.33

13.71

u/ml

—

Maternal care for known or suspected abnormality of pelvic organs

525

2912

1.24

4.91

1.1

6.39

3.64

u/ml

0.70

517

Medical treatment for female infertility

452

3624

1.25

4.90

1.1

1.99

4.65

u/ml

3.15

629

Meniscus derangement

751

4260

1.19

4.90

1.1

3.19

6.41

u/ml

2.29

591

Other disorders of Eustachian tube

270

1.97

4.90

1.1

4.38

4.02

u/ml

—

Vulvovaginal ulceration/inflammation in other diseases

121

794

1.55

4.89

1.1

2.26

5.31

u/ml

1.06

134

Disorders of adult personality and behaviour

525

4302

1.23

4.87

1.1

3.16

5.18

u/ml

0.99

673

ILD medications: azathioprine

231

1706

1.37

4.87

1.1

7.76

6.10

u/ml

0.20

255

Calcific aortic valvular stenosis

266

1942

1.33

4.86

1.1

15.94

9.96

u/ml

0.26

115

Calcific aortic valvular stenosis, operated

266

1942

1.33

4.86

1.1

15.94

9.96

u/ml

0.26

115

Abnormal blood-pressure reading, without diagnosis

400

1.78

4.85

1.1

4.61

6.58

u/ml

—

Zoster [herpes zoster]

228

1682

1.37

4.83

1.1

6.77

7.70

u/ml

0.11

168

Gout, FINNGEN

268

2018

1.33

4.83

1.1

10.76

9.00

u/ml

0.14

170

Dermatitis due to substances taken internally

514

1.68

4.81

1.1

2.53

4.06

u/ml

—

Unspecified kidney failure

106

676

1.58

4.80

1.1

16.75

11.10

u/ml

—

Ocular pain

138

934

1.50

4.80

1.1

4.99

4.02

u/ml

—

139

Fracture of lower leg, including ankle

821

6941

1.18

4.77

1.1

7.45

5.82

u/ml

0.31

911

Malignant neoplasm of breast, including Hilmo

507

4011

0.81

4.77

1.1

3.85

6.62

u/ml

1.36

491

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

500

4069

1.23

4.77

1.1

2.86

4.68

u/ml

0.95

697

Malignant neoplasm of breast, HER2-negative, including Hilmo

507

4011

0.81

4.76

1.1

3.85

6.62

u/ml

1.36

491

D07AA Corticosteroids, weak (group I)

266

2012

1.33

4.75

1.1

8.35

5.22

u/ml

0.30

279

Maternal care for other conditions predominantly related to pregnancy

435

3440

1.25

4.73

1.1

5.91

4.11

u/ml

0.31

605

Other and unspecified disorders of vitreous body

503

4057

1.23

4.72

1.1

5.26

8.73

u/ml

1.05

415

Diseases of the myoneural junction and muscle

149

1026

1.47

4.72

1.1

9.12

6.84

u/ml

0.17

111

Diplopia

175

1242

1.42

4.71

1.1

6.76

6.62

u/ml

0.01

148

Statin medication

1213

5969

1.15

4.70

1.1

6.65

5.15

u/ml

0.54

152

925

Spirochaetal infections, other/unspecified

118

776

1.54

4.70

1.1

3.89

4.79

u/ml

0.14

Scleritis and episcleritis

102

651

1.59

4.66

1.1

1.30

4.35

u/ml

1.61

Diseases of pulp and periapical tissues, including avohilmo

1865

8675

1.12

4.66

1.1

6.05

5.36

u/ml

0.19

170

1219

Personality disorders

491

4017

1.23

4.66

1.1

3.42

5.24

u/ml

0.75

624

Endometriosis ASRM stages 3,4

397

3175

1.26

4.66

1.1

3.99

5.73

u/ml

0.47

446

Vasomotor rhinitis (mode)

106

683

1.57

4.64

1.0

1.1

3.95

4.56

u/ml

0.07

Allergic urticaria

143

982

1.47

4.64

1.1

1.94

5.12

u/ml

1.51

145

Other and unspecified injuries of lower leg

129

868

1.51

4.63

1.1

2.94

4.98

u/ml

0.61

116

Alopecia areata

283

1.92

4.63

1.2

1.1

12.58

6.05

u/ml

—

Other problems related to primary support group, including family circumstances

221

1592

1.37

4.62

1.1

8.56

5.76

u/ml

0.48

244

L04AA Selective immunosuppressants

329

2575

1.29

4.61

1.1

6.40

6.34

u/ml

0.01

357

Other diseases of peritoneum

392

1.76

4.60

1.1

1.09

4.46

u/ml

—

Non-rheumatic valve diseases

553

3290

1.22

4.60

1.1

9.33

7.60

u/ml

0.22

374

Biological medication for rheuma

285

2191

1.31

4.60

1.1

8.13

5.53

u/ml

0.20

338

Mandibular retrognathia

130

876

1.50

4.59

1.0

1.1

9.07

4.28

u/ml

0.43

127

DVT of lower extremities

222

1646

1.36

4.57

1.1

5.35

8.80

u/ml

0.83

184

Other protozoal intestinal diseases

229

2.02

4.53

1.2

1.1

1.89

7.00

u/ml

—

Impotence

320

1.84

4.52

1.1

5.50

11.26

u/ml

—

Superficial injury of lower leg

391

3132

1.26

4.51

1.1

5.65

5.92

u/ml

0.05

426

Unspecific neurodegenerative disorder

367

1981

1.27

4.49

1.1

7.45

13.69

u/ml

—

Embedded teeth, including avohilmo

191

1391

1.39

4.48

1.1

4.78

4.37

u/ml

0.07

212

Congenital malformations of genital organs

182

1307

1.40

4.47

1.1

3.82

5.08

u/ml

0.40

213

Other septicaemia

435

3391

1.24

4.45

1.1

16.59

7.68

u/ml

0.45

366

Valvular heart disease excluding rheumatic fever

556

3324

1.21

4.45

1.1

9.33

7.69

u/ml

0.21

378

Testicular hypofunction

251

1.95

4.44

1.1

0.83

5.61

u/ml

—

Coxarthrosis, primary

664

4740

1.19

4.44

1.1

4.89

8.99

u/ml

1.70

449

Rheumatoid arthritis, including avohilmo

513

4235

1.22

4.44

1.1

3.02

7.58

u/ml

3.18

494

Melanocytic naevi

461

3768

1.23

4.43

1.1

6.02

5.89

u/ml

0.02

521

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

695

5873

1.18

4.43

1.1

4.47

5.07

u/ml

0.22

895

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

538

4415

1.21

4.40

1.1

6.15

5.00

u/ml

0.31

667

Other cataract

498

3093

1.22

4.40

1.1

10.43

7.84

u/ml

0.39

337

Otalgia

125

846

1.50

4.38

1.1

7.42

5.27

u/ml

—

115

Mental disorders, not otherwise specified

150

1052

1.44

4.38

1.1

6.06

4.29

u/ml

0.40

174

Strabismus

418

3379

1.24

4.36

1.1

2.26

6.83

u/ml

4.14

458

Spontaneous abortion

861

5000

1.17

4.36

1.1

5.00

4.77

u/ml

0.05

733

L04AD Calcineurin inhibitors

155

1095

1.43

4.33

1.1

16.27

6.38

u/ml

—

159

Social phobias

168

1205

1.41

4.32

1.1

3.95

4.25

u/ml

0.05

201

Psoriasis vulgaris

247

1879

1.32

4.31

1.1

2.58

6.64

u/ml

2.08

245

Other noninflammatory disorders of vagina

129

882

1.48

4.30

1.1

2.82

6.92

u/ml

0.87

123

Other predominantly sexually transmitted diseases, not elsewhere classified

403

3263

1.24

4.28

1.1

3.80

4.91

u/ml

0.37

516

Heterophoria

136

941

1.46

4.27

1.1

1.85

5.43

u/ml

1.45

137

Polycystic ovarian syndrome, broad definition

249

1903

1.32

4.27

1.1

1.50

4.23

u/ml

3.20

317

Endometriosis diagnosis and infertility diagnosis occurring together

205

1523

1.36

4.26

1.1

2.21

5.27

u/ml

2.02

258

ILD, hospital admissions 3, with pneumonia sepsis

554

1.60

4.26

1.2

1.1

11.55

9.91

u/ml

—

SLE, ICD10

350

1.78

4.25

1.1

0.78

5.45

u/ml

—

SLE, strict definition

350

1.78

4.25

1.1

0.78

5.45

u/ml

—

Other and unspecified injuries of wrist and hand

418

1.71

4.22

1.1

2.76

6.39

u/ml

—

Other degenerative diseases of the nervous system

317

1856

1.28

4.22

1.1

3.51

9.08

u/ml

1.48

238

Fracture of forearm

858

6803

1.16

4.22

1.1

12.02

5.94

u/ml

1.20

875

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

510

1.63

4.21

1.1

2.52

6.65

u/ml

—

Amenorrhoea

144

1011

1.44

4.21

1.1

1.74

6.30

u/ml

2.18

168

Other viral diseases, not elsewhere classified

457

3735

1.22

4.19

1.1

6.26

5.84

u/ml

0.05

550

Dementia, including avohilmo

416

2313

1.24

4.18

1.1

5.37

12.35

u/ml

—

124

Fall on and from stairs and steps

353

2822

1.26

4.18

1.1

13.45

7.16

u/ml

0.61

349

Psoriatic and enteropathic arthropathies

162

1162

1.41

4.16

1.0

1.1

2.62

7.48

u/ml

1.38

169

Dermatophytosis

919

8003

1.15

4.14

1.1

2.14

6.09

u/ml

8.01

127

1065

Cluster headache, strict

360

1.75

4.14

1.0

1.1

2.38

4.08

u/ml

—

Other necrotizing vasculopathies

552

1.59

4.11

1.1

0.85

8.26

u/ml

—

Polyhydramnios

103

681

1.54

4.11

1.1

2.28

3.73

u/ml

—

135

Any event in cancer register

1284

8498

0.89

4.11

1.1

4.70

5.45

u/ml

0.23

183

1152

Other specified/unspecified soft tissue disorders

398

1.71

4.10

1.0

1.1

2.76

5.71

u/ml

—

Misadventures to patients during surgical and medical care

188

1385

1.37

4.10

1.1

4.57

7.56

u/ml

0.49

155

190

1315

1.37

4.10

1.1

34.95

13.40

u/ml

—

Artificial joint re-operation

506

1.62

4.08

1.1

7.14

9.23

u/ml

—

Dementia

388

2150

1.25

4.07

1.1

5.69

12.82

u/ml

—

112

Maternal care related to the fetus and amniotic cavity and possible delivery problems

867

4404

1.16

4.06

1.1

5.82

4.56

u/ml

0.33

115

733

Superficial injury of shoulder and upper arm

161

1159

1.40

4.06

1.1

2.19

6.04

u/ml

1.65

149

Special screening examination for neoplasms

339

1.76

4.05

1.1

0.93

8.79

u/ml

—

Umbilical hernia

337

2691

1.26

4.04

1.1

9.01

6.71

u/ml

0.27

359

Other disorders of conjunctiva

170

1237

1.39

4.01

1.1

6.47

9.78

u/ml

0.41

118

Disorder of the sleep-wake schedule

184

2.07

4.01

1.0

1.1

1.21

9.83

u/ml

—

Cutaneous abscess, furuncle and carbuncle

382

3097

1.24

4.01

1.1

9.74

5.88

u/ml

0.28

459

Other abnormal immunological findings in serum

212

1.99

3.99

1.1

11.26

5.41

u/ml

—

Gonarthrosis,primary

1153

6275

1.13

3.98

1.1

6.02

7.10

u/ml

0.29

110

742

Suppurative and unspecified otitis media

681

5159

1.18

3.98

1.1

8.30

4.77

u/ml

0.61

751

Acute lymphadenitis

100

661

1.53

3.97

1.1

9.20

4.49

u/ml

0.82

Habitual aborter

299

1.82

3.96

1.1

1.43

4.28

u/ml

—

Early onset COPD, excluding more controls

215

1623

1.33

3.96

1.1

15.88

7.77

u/ml

0.27

215

Other fall from one level to another

324

2582

1.26

3.96

1.1

5.51

6.02

u/ml

0.10

342

Lesion of plantar nerve

542

1.59

3.96

1.1

4.25

5.93

u/ml

—

Other viral diseases

497

4131

1.21

3.95

1.1

7.04

5.64

u/ml

0.20

603

Postpartum care and examination

315

1576

1.28

3.94

1.1

5.71

3.66

u/ml

0.27

255

Maternal care for other known or suspected fetal problems

528

2790

1.21

3.94

1.1

7.87

3.50

u/ml

1.00

505

Testicular dysfunction

284

1.83

3.93

1.1

0.83

9.46

u/ml

—

Injury of muscle and tendon at shoulder and upper arm level

395

3220

1.23

3.92

1.1

5.53

7.80

u/ml

0.62

397

Non-small cell lung cancer, squamous

224

0.27

3.91

1.0

1.1

—

20.59

—

Non-small cell lung cancer, squamous, helper endpoint

228

0.26

3.89

1.0

1.1

—

14.49

—

Unspecified abortion

553

1.58

3.89

1.1

9.59

7.27

u/ml

0.17

Hypertrophy of breast in women and men

326

2609

1.26

3.88

1.1

3.57

6.21

u/ml

0.98

371

Transplanted organ and tissue status

128

893

1.45

3.87

1.2

1.1

27.65

6.86

u/ml

0.63

129

Immunodeficiency with predominantly antibody defects

272

1.84

3.85

1.2

1.1

29.93

6.48

u/ml

—

Medical abortion

1177

5658

1.13

3.85

1.1

6.68

4.95

u/ml

0.42

147

773

Additional codes for the location of defect, injury or illness

546

1.58

3.85

1.1

6.19

4.69

u/ml

—

Failed induction of labour

137

972

1.43

3.84

1.1

2.96

2.64

u/ml

0.09

158

Lichen sclerosus et atrophicus

141

1003

1.42

3.84

1.1

7.88

5.91

u/ml

0.13

113

Septicaemia

489

3813

1.20

3.83

1.1

14.98

7.98

u/ml

0.42

417

Olecranon bursitis

398

1.68

3.83

1.1

0.78

7.76

u/ml

—

Malignant neoplasm

1107

7391

0.88

3.83

1.1

5.25

5.94

u/ml

0.18

161

980

Disturbances of smell and taste

346

1.73

3.82

1.0

1.1

6.17

5.47

u/ml

—

Acute bronchitis

557

4612

1.19

3.81

1.1

5.51

6.72

u/ml

0.31

597

Other and unspecified injuries of head

651

1.52

3.80

1.1

4.36

6.69

u/ml

—

Reactive arthropathies

119

823

1.46

3.78

1.1

6.99

7.95

u/ml

0.09

120

Cluster headache, wide,, including avohilmo

581

1.55

3.77

1.0

1.1

1.96

4.18

u/ml

0.82

Care involving dialysis

620

1.53

3.77

1.1

45.92

7.35

u/ml

—

Sacrococcygeal disorders, not elsewhere classified

296

1.79

3.75

1.1

0.99

5.41

u/ml

—

Idiopathic urticaria

246

1.88

3.73

1.2

1.1

1.80

6.16

u/ml

—

Alcoholic liver disease

104

702

1.49

3.73

1.1

8.32

7.52

u/ml

—

Explicit Sepsis

540

4253

1.19

3.73

1.1

11.37

7.33

u/ml

0.31

505

Sacroiliitis, not elsewhere classified

535

1.57

3.72

1.1

2.24

5.00

u/ml

—

Benign neoplasm: Descending colon

487

1.60

3.72

1.1

0.92

5.23

u/ml

—

Primary coxarthrosis, bilateral

288

2283

1.27

3.70

1.1

4.42

10.73

u/ml

1.04

184

Idiopathic pulmonary fibrosis

464

1.61

3.70

1.1

22.80

13.58

u/ml

—

Other diseases of pancreas

631

1.52

3.69

1.1

15.81

6.02

u/ml

—

Generalized epilepsy

505

1.59

3.69

1.1

2.06

4.68

u/ml

0.80

Deep bite

199

1318

1.34

3.69

1.1

10.93

4.67

u/ml

0.44

170

Necrosis of pulp, including avohilmo

941

8270

1.14

3.67

1.1

4.72

5.35

u/ml

0.22

109

1214

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

396

3255

1.22

3.67

1.1

5.03

6.53

u/ml

0.41

464

Prepatellar bursitis

335

1.72

3.67

1.1

1.76

7.61

u/ml

—

Seropositive rheumatoid arthritis

307

2446

1.26

3.67

1.1

3.96

8.83

u/ml

2.06

305

Impacted cerumen

118

820

1.45

3.66

1.1

3.38

7.24

u/ml

—

Other disorders of adrenal gland

436

1.63

3.63

1.1

2.62

6.42

u/ml

—

Transient global amnesia

100

674

1.50

3.63

1.2

1.1

6.94

6.63

u/ml

—

Degeneration of macula and posterior pole

468

3105

1.20

3.62

1.1

15.68

10.39

u/ml

0.42

212

Thyroid crisis or storm

5.76

3.61

1.0

1.1

—

16.52

—

Acute pancreatitis (for exclusion)

228

1763

1.30

3.60

1.1

5.32

7.61

u/ml

0.35

206

AV-block

167

1079

1.36

3.59

1.1

4.88

8.69

u/ml

—

Deep endometriosis

161

1187

1.37

3.58

1.1

6.20

4.66

u/ml

0.12

155

Presence of other functional implants

654

3889

1.17

3.58

1.1

7.56

8.61

u/ml

0.13

386

Biomechanical lesions, not elsewhere classified

430

1.63

3.57

1.1

5.30

6.62

u/ml

—

Causalgia

151

2.11

3.57

1.1

—

8.38

—

Cyst of kidney

508

1.57

3.57

1.1

2.57

7.16

u/ml

—

Lung cancer and mesothelioma

1106

0.66

3.56

1.1

29.30

14.65

u/ml

—

Other diseases of blood and blood-forming organs, wide

281

2235

1.26

3.55

1.1

12.90

7.20

u/ml

0.39

263

Duodenal ulcer

612

1.51

3.54

1.1

6.91

6.50

u/ml

—

L02BG Aromatase inhibitors

267

3351

0.79

3.53

1.1

2.28

8.76

u/ml

4.26

336

Hyperparathyroidism

212

1610

1.31

3.52

1.1

33.05

8.98

u/ml

0.60

149

Antepartum haemorrhage, not elsewhere classified

177

1329

1.35

3.52

1.1

4.68

3.51

u/ml

0.31

254

Other coagulation defects

115

804

1.45

3.50

1.1

1.98

3.85

u/ml

0.74

106

Gluteal tendinitis

348

1.69

3.49

1.2

1.1

0.58

6.33

u/ml

—

Solid cancers, helper endpoint

1095

7255

0.89

3.49

1.1

5.22

5.91

u/ml

0.17

155

958

Other benign neoplasms of skin

473

3975

1.19

3.49

1.1

6.69

7.84

u/ml

0.24

439

Abnormalities of gait and mobility

133

954

1.40

3.48

1.1

46.22

7.64

u/ml

—

Speech and linguistic disorders, excluding more controls

153

1057

1.38

3.47

1.1

3.98

5.79

u/ml

0.25

157

Type 2 diabetes, wide definition

1072

6096

1.13

3.47

1.1

6.07

6.56

u/ml

0.13

805

Convulsions, not elsewhere classified

334

2683

1.23

3.44

1.1

3.99

7.28

u/ml

0.98

383

Heart failure and antihypertensive medication

278

1440

1.27

3.43

1.1

21.97

8.74

u/ml

0.65

197

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

290

1.76

3.42

1.1

2.03

5.91

u/ml

—

Generalized epilepsy, strict definition

261

1.80

3.41

1.1

1.27

6.03

u/ml

—

Episcleritis

563

1.53

3.41

1.1

1.37

4.38

u/ml

1.42

Exclusions for E4_PCOS_CONSORTIUM

1337

7544

1.11

3.40

1.1

3.39

5.34

u/ml

1.64

168

1037

Ischaemic heart disease, wide definition

948

5183

1.14

3.40

1.1

11.38

6.85

u/ml

0.73

605

Pacemaker

298

2296

1.25

3.40

1.1

11.11

10.78

u/ml

0.02

161

Pregnancy examination and test

341

1721

1.24

3.39

1.1

2.34

4.37

u/ml

0.70

279

Other local infections of skin and subcutaneous tissue

136

985

1.39

3.38

1.1

7.25

5.13

u/ml

0.16

133

Atrophic disorders of skin

208

1606

1.30

3.37

1.1

5.91

5.49

u/ml

0.04

189

Other benign neoplasms of connective and other soft tissue

134

969

1.40

3.37

1.1

10.16

5.56

u/ml

0.22

119

Superficial injury of ankle and foot

198

1520

1.31

3.36

1.1

3.94

6.05

u/ml

0.61

224

Childhood allergy (age < 16)

338

2274

1.23

3.36

1.1

6.50

4.55

u/ml

0.42

349

Pregnancy with abortive outcome

1229

5748

1.12

3.36

1.1

7.97

4.93

u/ml

0.86

148

785

Medicines for HER+ breast cancer

369

4225

0.82

3.36

1.1

2.04

7.73

u/ml

5.59

463

Dysplasia of cervi uteri

431

2602

1.21

3.35

1.1

3.42

5.18

u/ml

0.92

402

Pre-eclampsia or poor fetal growth

586

5018

1.17

3.35

1.1

7.86

4.24

u/ml

0.53

799

COPD (mode)

297

1874

1.25

3.34

1.1

16.57

9.51

u/ml

0.25

189

Ankylosing spondylitis

112

786

1.44

3.34

1.1

2.52

6.28

u/ml

—

112

Atrial fibrillation and flutter

416

2239

1.21

3.33

1.1

5.79

7.05

u/ml

0.23

341

Congenital malformations of ovaries, fallopian tubes and broad ligaments

107

747

1.45

3.32

1.0

1.1

4.31

4.71

u/ml

—

129

Dermatophytosis

152

1124

1.36

3.32

1.1

3.13

6.49

u/ml

1.26

128

Combinations of oral blood glucose lowering drugs

301

2433

1.24

3.32

1.1

4.28

9.30

u/ml

1.13

286

Other peripheral vascular diseases

112

788

1.44

3.30

1.1

8.85

4.41

u/ml

—

101

Placental disorders

116

2.24

3.30

1.1

2.65

5.15

u/ml

—

Polyarthritis, unspecified

293

1.73

3.30

1.1

4.69

4.32

u/ml

—

Acute pharyngitis

255

2009

1.27

3.30

1.1

4.27

5.73

u/ml

0.50

332

Psoriatic arthropathies

128

922

1.40

3.29

1.0

1.1

1.32

8.49

u/ml

2.35

132

Benign neoplasm of urinary organs

354

1.66

3.28

1.1

0.68

4.92

u/ml

—

Malignant neoplasm, wide definition for exclusion

1183

7719

0.90

3.27

1.1

4.78

5.73

u/ml

0.29

175

1036

Other Crohn's disease

108

757

1.44

3.27

1.1

16.82

3.21

u/ml

0.62

107

Cardiac murmurs and other cardiac sounds

149

1090

1.36

3.26

1.1

20.35

6.82

u/ml

0.53

144

Perforation of tympanic membrane

135

984

1.38

3.25

1.1

18.57

3.97

u/ml

—

123

Gout, idiopatic and unspecified

219

1710

1.29

3.24

1.1

14.55

9.67

u/ml

—

148

Influenza and pneumonia

1786

10401

1.09

3.24

1.1

7.59

5.11

u/ml

0.93

167

1459

Colorectal adenocarcinoma

192

1470

1.31

3.24

1.0

1.1

4.92

11.20

u/ml

0.78

112

Dystonia

522

1.53

3.22

1.1

8.86

5.89

u/ml

—

Agranulocytosis

147

1088

1.36

3.22

1.1

4.88

6.03

u/ml

0.15

131

Tumor necrosis factor alpha inhibitors

249

1980

1.27

3.21

1.1

9.18

5.87

u/ml

0.23

307

Other keratitis

165

1243

1.34

3.21

1.1

6.36

5.93

u/ml

0.06

169

Dislocation, sprain and strain of joints and ligaments of thorax

326

1.68

3.21

1.1

17.97

5.83

u/ml

—

Other otitis externa (chronic)

628

1.48

3.20

1.1

2.65

4.91

u/ml

—

Effects of other external causes

319

1.69

3.20

1.1

21.20

6.22

u/ml

—

Reactive arthropathies, FINNGEN

101

702

1.45

3.20

1.1

2.30

5.96

u/ml

1.35

Other peripheral vertigo

114

810

1.42

3.19

1.0

1.1

2.61

6.33

u/ml

—

Iridocyclitis

304

2473

1.24

3.19

1.1

3.06

7.39

u/ml

1.77

320

Cluster headache, strict, including avohilmo

556

1.51

3.18

1.0

1.1

2.09

4.10

u/ml

—

Cerebral palsy and other paralytic syndromes

149

1108

1.36

3.16

1.1

1.11

5.07

u/ml

—

138

Acute nasopharyngitis (common cold)

161

1205

1.34

3.13

1.1

8.48

5.98

u/ml

0.33

204

Non-allergic asthma (mode), excluding more controls

247

1950

1.26

3.11

1.1

4.41

7.49

u/ml

0.57

257

Non-allergic asthma (mode)

247

1950

1.26

3.11

1.1

4.41

7.79

u/ml

0.63

258

Haemorrhage in early pregnancy

501

4168

1.18

3.09

1.1

3.89

4.04

u/ml

0.03

652

Effects of foreign body entering through natural orifice

329

2708

1.22

3.09

1.1

9.74

6.16

u/ml

0.54

392

Benign neoplasm: Liver/bile ducts

277

1.73

3.08

1.1

1.20

5.90

u/ml

—

Astigmatism

666

1.46

3.07

1.1

31.62

6.95

u/ml

0.59

Malignant neoplasm of skin

443

3588

0.84

3.07

1.1

8.42

8.63

u/ml

0.02

356

Familial hypercholesterolemia

147

1096

1.35

3.07

1.0

1.1

16.40

9.41

u/ml

—

Other diseases of gallbladder

338

1.65

3.06

1.1

5.00

5.21

u/ml

—

Other abnormal products of conception

667

3846

1.15

3.05

1.1

5.26

4.33

u/ml

0.28

669

Colorectal cancer

236

1834

1.26

3.05

1.1

5.06

10.45

u/ml

1.00

149

Congenital ovarian cysts

595

1.49

3.05

1.0

1.1

3.68

3.66

u/ml

—

101

Nontoxic multinodular goitre

238

1895

1.26

3.04

1.1

7.67

9.41

u/ml

0.14

174

Acquired clawhand, clubhand, clawfoot and clubfoot

2.76

3.04

1.0

—

10.98

—

Covid-19 suspected case

246

3057

0.80

3.01

1.0

1.1

2.34

5.56

u/ml

2.91

455

Myopia

211

1660

1.28

3.01

1.1

6.74

5.21

u/ml

0.20

252

Open wound of ankle and foot

140

1041

1.36

3.00

1.1

0.84

4.78

u/ml

2.51

138

Familial hypercholesterolemia, with ischemic heart disease

546

1.49

3.00

1.1

25.78

6.77

u/ml

—

Localized swelling, mass and lump of skin and subcutaneous tissue

417

3520

1.19

2.99

1.1

2.02

6.29

u/ml

3.83

450

Keratitis

507

4350

1.17

2.99

1.1

3.92

6.27

u/ml

1.18

590

Disorders of breast

836

6738

1.13

2.96

1.1

2.87

5.67

u/ml

3.15

117

867

Pregnancy, childbirth and the puerperium

494

2195

1.18

2.96

1.1

8.64

4.59

u/ml

0.69

251

Superficial injury of forearm

150

1130

1.34

2.96

1.1

5.74

4.81

u/ml

0.13

158

Injury of muscle and tendon at wrist and hand level

174

1338

1.31

2.96

1.1

3.12

5.92

u/ml

0.72

192

Vitamin deficiency, wide

444

1.55

2.95

1.1

11.72

4.48

u/ml

—

Vitamin deficiency

444

1.55

2.95

1.1

11.73

4.48

u/ml

—

Hypertrophy of tongue papillae

108

2.19

2.95

1.2

1.1

8.28

7.86

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

103

731

1.42

2.94

1.1

3.91

5.12

u/ml

0.21

Spontaneous rupture of synovium and tendon

681

1.44

2.93

1.1

3.71

9.01

u/ml

—

Benign neoplasm: Skin of other and unspecified parts of face

127

934

1.37

2.93

1.1

10.85

6.13

u/ml

0.61

103

Recurrent dislocation of patella

102

725

1.42

2.91

1.0

1.1

2.04

4.66

u/ml

1.02

135

Superficial injury of wrist and hand

328

2718

1.21

2.91

1.1

8.89

5.99

u/ml

0.42

402

Other chondrocalcinosis

2.49

2.91

1.1

—

14.79

—

Conjunctivitis (acute, non atopic)

427

3610

1.18

2.90

1.1

2.68

6.35

u/ml

2.45

495

Endometriosis of rectovaginal septum and vagina

114

826

1.39

2.90

1.2

1.1

7.63

6.74

u/ml

0.05

108

Placenta praevia

652

1.45

2.88

1.1

2.09

2.90

u/ml

0.35

125

Anterior Iridocyclitis

269

2187

1.24

2.88

1.1

3.06

7.22

u/ml

1.62

280

Spermatocele

414

1.56

2.88

1.1

14.26

10.80

u/ml

—

Ectopic testis

2.89

2.88

1.2

1.1

—

13.40

—

Benign neoplasm of eye and adnexa

124

912

1.37

2.87

1.1

3.80

5.03

u/ml

0.27

Malignant neoplasm of small intestine, including Hilmo

208

1.81

2.85

1.1

1.98

14.18

u/ml

—

Other and unspecified coagulation defects

562

1.48

2.85

1.1

2.28

4.26

u/ml

0.58

Otitis media, unspecified

201

1457

1.28

2.85

1.1

19.99

4.25

u/ml

0.70

193

Other and unspecified local infections of skin and subcutaneous tissue

126

931

1.36

2.84

1.1

7.25

4.43

u/ml

0.22

125

Paroxysmal tachycardia

320

2215

1.21

2.83

1.1

4.74

6.78

u/ml

0.46

333

Other infective otitis externa

546

1.48

2.83

1.1

24.29

4.47

u/ml

0.53

Generalized epilepsy, mode (most common among epilepsy diagnosis)

354

1.61

2.83

1.1

1.13

5.89

u/ml

—

Dialysis, with operation codes

138

1034

1.34

2.83

1.2

1.1

30.41

7.10

u/ml

0.66

132

Shock, not elsewhere classified

2.53

2.83

1.1

—

19.98

—

Exposure to other and unspecified inanimate mechanical forces

106

763

1.40

2.81

1.1

21.66

4.78

u/ml

0.82

103

Retention of urine

326

2219

1.21

2.79

1.1

9.74

7.79

u/ml

0.18

218

Benign mammary dysplasia

187

1465

1.29

2.78

1.1

2.76

8.58

u/ml

1.93

159

Contact with machinery

116

849

1.38

2.77

1.1

6.65

6.88

u/ml

0.02

113

Seborrhoeic keratosis

236

1901

1.25

2.76

1.1

14.05

8.42

u/ml

0.32

189

Perioral dermatitis

241

1.74

2.75

1.1

1.34

6.10

u/ml

—

Follicular cysts of skin and subcutaneous tissue

230

1850

1.25

2.74

1.1

6.98

6.56

u/ml

0.04

236

Injury of muscle and tendon at hip and thigh level

126

937

1.36

2.74

1.1

5.33

5.48

u/ml

0.02

126

Other CVD

185

1449

1.28

2.74

1.1

5.73

8.95

u/ml

—

114

Other disorders of male genital organs

271

1.68

2.74

1.3

1.0

8.94

4.21

u/ml

—

Cerebrovascular diseases (FINNGEN)

435

2620

1.18

2.73

1.1

5.28

6.36

u/ml

0.25

411

Synovial cyst of popliteal space [Baker]

583

1.45

2.73

1.1

1.03

8.59

u/ml

—

Posteruptive colour changes of dental hard tissues

3.93

2.72

1.0

—

17.27

—

Urethral stricture

333

1.61

2.72

1.1

0.54

9.24

u/ml

—

Cytomegaloviral disease

212

1.78

2.71

1.2

1.1

14.00

8.64

u/ml

—

Maternal care for known or suspected malpresentation of fetus

392

2403

1.19

2.71

1.1

5.33

3.59

u/ml

0.30

446

Hidradenitis suppurativa

430

1.53

2.71

1.0

1.1

0.60

4.65

u/ml

—

Delivery, wide proxy

569

2622

1.16

2.69

1.1

6.53

4.82

u/ml

0.27

318

Nontoxic goitre/thyroid nodule

379

3208

1.19

2.69

1.1

5.69

7.73

u/ml

0.26

327

Disorders of oesophagus in diseases classified elsewhere

119

2.05

2.68

1.1

—

8.95

—

Female infertility, tubal origin

611

1.44

2.68

1.1

0.88

5.75

u/ml

—

112

Hypotension

156

1199

1.31

2.68

1.1

6.72

9.24

u/ml

—

Female infertility, associated with anovulation

161

1247

1.30

2.66

1.1

1.20

4.25

u/ml

3.02

220

Supervision of normal pregnancy

440

2144

1.18

2.65

1.1

3.93

4.55

u/ml

0.14

364

Other/unspecified rheumatoid arthritis

142

1081

1.32

2.64

1.1

5.33

10.01

u/ml

—

Congenital malformations and deformations of the musculoskeletal system

155

1189

1.31

2.64

1.1

2.34

4.88

u/ml

1.18

180

Diffuse brain injury

274

1.66

2.63

1.2

1.1

11.70

4.70

u/ml

—

Noise effects on inner ear

282

1.65

2.63

1.1

6.84

3.60

u/ml

—

Femoral hernia

321

1.61

2.62

1.2

1.1

19.26

8.35

u/ml

—

Peripheral arterial reconstruction

139

1055

1.32

2.62

1.1

46.64

8.42

u/ml

—

Generalized skin eruption due to drugs and medicaments

361

1.57

2.62

1.1

3.20

6.39

u/ml

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

991

7085

1.11

2.60

1.1

5.11

4.95

u/ml

0.03

156

983

Viral hepatitis, IBD co-morbidity

490

1.48

2.60

1.1

1.62

7.09

u/ml

—

122

Hypertrophy of breast

288

2388

1.21

2.60

1.1

3.48

6.38

u/ml

1.01

350

Acute and subacute iridocyclitis

252

2062

1.23

2.58

1.1

3.27

7.59

u/ml

1.49

263

Nondiabetic hypoglycaemic coma

3.39

2.57

1.1

1.0

—

7.60

—

Conduction disorders

308

2078

1.21

2.57

1.1

3.31

7.37

u/ml

1.65

224

Anogenital herpesviral [herpes simplex] infection

115

854

1.36

2.57

1.1

3.69

4.00

u/ml

0.06

144

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

427

1.52

2.57

1.1

23.20

5.36

u/ml

—

Ingrowing nail

550

1.45

2.56

1.1

2.80

4.98

u/ml

—

Pre-eclampsia or eclampsia

378

3217

1.18

2.55

1.1

7.27

5.16

u/ml

0.15

501

Purpura and other haemorrhagic conditions

169

1324

1.28

2.55

1.1

2.22

6.25

u/ml

2.15

165

Amputation

642

1.41

2.53

1.1

38.87

8.99

u/ml

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

676

1.40

2.52

1.0

1.1

1.21

8.92

u/ml

—

Otitis externa, unspecified

160

1247

1.29

2.52

1.1

5.97

5.14

u/ml

0.15

174

Superficial injury of hip and thigh

170

1336

1.28

2.49

1.1

3.53

6.62

u/ml

—

146

Car occupant injured in noncollision transport accident

390

1.53

2.49

1.1

14.60

5.06

u/ml

—

Salpingitis and oophoritis

249

2045

1.22

2.49

1.1

2.24

6.65

u/ml

2.20

263

Other and unspecified injuries of ankle and foot

488

1.47

2.48

1.0

1.1

4.58

5.11

u/ml

0.05

Somnolence, stupor and coma

351

1.55

2.45

1.1

11.52

6.16

u/ml

—

Uterine polyps

134

1025

1.32

2.44

1.1

2.69

6.13

u/ml

1.00

134

Alzheimer disease, including avohilmo

295

1728

1.21

2.44

1.1

10.12

14.07

u/ml

—

Mental and behavioural disorders due to tobacco

109

809

1.36

2.44

1.1

25.27

5.39

u/ml

—

112

Other diseases of arteries and capillaries

102

750

1.37

2.42

1.2

1.1

18.15

5.21

u/ml

1.52

Inflammatory disease of cervix uteri

590

1.42

2.42

1.1

4.54

7.12

u/ml

—

Acute suppurative otitis media

497

4045

1.15

2.42

1.1

9.27

4.38

u/ml

0.77

605

Diagnoses used for exclusion with ILD

274

2278

1.21

2.41

1.1

2.85

7.99

u/ml

2.71

246

Other disorders of veins

540

4712

1.14

2.40

1.1

3.18

6.84

u/ml

2.39

594

Paralytic ileus

235

1.68

2.40

1.1

—

9.75

—

Enteropathic arthropathies

228

1.70

2.40

1.1

1.0

5.42

4.98

u/ml

—

Smoking dependency

109

812

1.35

2.39

1.1

25.27

5.37

u/ml

—

111

Pedal cyclist injured in collision with motor vehicle

330

1.57

2.38

1.1

0.67

5.62

u/ml

—

Postinfectious hypothyroidism

2.92

2.38

1.0

1.1

—

2.99

—

Disorders of orbit

411

1.50

2.36

1.1

2.28

6.33

u/ml

—

Diseases of peritoneum

117

883

1.33

2.35

1.1

1.06

6.15

u/ml

—

103

Other disorders of pigmentation

387

1.52

2.35

1.1

2.83

4.32

u/ml

—

Erysipelas

669

5267

1.13

2.35

1.1

15.31

6.48

u/ml

0.91

629

Burns and corrosions

189

1518

1.25

2.35

1.1

7.76

5.87

u/ml

0.25

217

Other heart diseases

807

4731

1.12

2.34

1.1

9.25

5.29

u/ml

0.69

101

766

Superficial injury of abdomen, lower back and pelvis

209

1698

1.24

2.34

1.1

4.67

4.94

u/ml

0.04

230

Adenocarcinoma and papilloma adenocarcinoma of rectum

644

1.39

2.33

1.0

1.1

1.21

9.09

u/ml

—

Pedal cyclist injured in noncollision transport accidents

157

1235

1.28

2.33

1.1

10.02

4.99

u/ml

0.46

174

Pre-eclampsia

356

3043

1.18

2.32

1.1

7.27

5.30

u/ml

0.14

481

Family history of other specific disorders

163

1.83

2.32

1.1

—

8.99

—

Malignant melanoma of skin

911

0.69

2.32

1.1

5.44

7.41

u/ml

—

Factitial dermatitis

2.85

2.31

1.1

1.0

—

0.91

—

Other respiratory disorders and diseases

193

1556

1.25

2.30

1.1

11.07

8.40

u/ml

—

141

Other diseases of the respiratory system

193

1556

1.25

2.30

1.1

11.07

8.40

u/ml

—

141

Pterygium

185

1.75

2.30

1.2

1.1

5.37

7.95

u/ml

—

Early lumbar disc prolapse, operated

156

1229

1.28

2.29

1.1

4.83

4.60

u/ml

0.04

237

Diseases of arteries, arterioles and capillaries

742

4908

1.12

2.29

1.1

16.75

7.20

u/ml

0.95

506

Mandibular retrognathia AND surgery (BSSO)

302

1.58

2.28

1.0

1.1

4.96

3.41

u/ml

—

All influenza (not pneumonia)

195

1577

1.24

2.28

1.1

6.84

5.24

u/ml

0.21

229

Heart failure,strict

518

3202

1.14

2.28

1.1

22.76

7.99

u/ml

1.07

299

Other diseases of biliary tract

665

1.38

2.26

1.1

5.54

8.17

u/ml

0.31

Acute generalized exanthematous pustulosis

407

1.49

2.26

1.0

1.1

3.20

5.87

u/ml

—

Nonspecific lymphadenitis

624

1.39

2.25

1.0

1.1

2.01

5.65

u/ml

1.46

Oligomenorrhoea

449

1.47

2.25

1.1

2.73

6.07

u/ml

—

Other and unspecified mood [affective] disorders

123

943

1.32

2.25

1.1

2.35

3.62

u/ml

0.47

150

Spinal instabilities

248

1.64

2.24

1.1

3.95

6.70

u/ml

—

Cholecystitis

143

1117

1.29

2.24

1.1

8.03

6.32

u/ml

0.12

110

Superficial injury of neck

233

1.66

2.24

1.1

1.07

4.06

u/ml

—

Fracture of foot, except ankle

364

3126

1.17

2.24

1.1

10.75

5.86

u/ml

0.40

453

Emotionally unstable personality disorder

224

1845

1.22

2.23

1.1

2.14

5.30

u/ml

2.41

290

Malignant melanoma

1217

0.74

2.23

1.1

6.14

8.14

u/ml

—

118

Benign neoplasm: Pituitary gland, craniopharyngeal duct

508

1.43

2.22

1.1

6.01

4.45

u/ml

—

Chronic apical periodontitis

1877

9979

1.07

2.21

1.1

5.48

5.22

u/ml

0.07

204

1379

Delayed puberty

2.13

2.21

1.1

—

11.57

—

Pilonidal cyst

131

1016

1.30

2.20

1.0

1.1

0.98

5.06

u/ml

2.83

176

Laparoscopic right hemicolectomy

385

1.49

2.19

1.1

2.99

6.07

u/ml

0.45

Essential (haemorrhagic) thrombocythaemia

297

1.57

2.18

1.1

0.89

8.52

u/ml

—

Need for immunization against other single viral diseases

180

0.38

2.18

1.0

1.1

—

9.86

—

Mental and behavioural disorders due to alcohol

549

5952

0.88

2.18

1.1

4.62

5.44

u/ml

0.19

857

Bronchitis, not specified as acute or chronic

730

1.35

2.17

1.1

7.90

5.75

u/ml

—

Benign neoplasm: Choroid

510

1.42

2.17

1.1

4.17

5.73

u/ml

—

Cramp and spasm

444

1.46

2.17

1.1

10.70

4.58

u/ml

—

Other congenital malformations

138

1080

1.29

2.16

1.1

2.86

5.38

u/ml

0.93

172

Sequelae of injuries of lower limb

121

931

1.31

2.16

1.1

24.18

4.68

u/ml

0.52

131

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

102

766

1.34

2.15

1.2

1.1

1.61

5.54

u/ml

—

Pregnancy hypertension

756

6108

1.11

2.15

1.1

5.06

4.42

u/ml

0.10

930

Gout, strict definition

147

1159

1.27

2.15

1.1

19.00

10.88

u/ml

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

152

1.81

2.15

1.1

0.72

9.97

u/ml

—

Venous thromboembolism

634

5470

1.12

2.15

1.1

3.85

7.73

u/ml

2.31

594

Other disorders of the genitourinary system

150

1187

1.27

2.15

1.1

4.05

9.44

u/ml

0.83

113

Gout, unspecified

168

1346

1.25

2.15

1.1

18.78

9.67

u/ml

—

108

Premature rupture of membranes

429

2674

1.15

2.12

1.1

3.79

3.42

u/ml

0.08

474

Vestibular neuronitis

103

777

1.34

2.12

1.1

7.81

5.02

u/ml

—

Other congenital malformations of male genital organs

2.33

2.11

1.1

—

10.31

—

Unstable angina pectoris

331

2231

1.17

2.10

1.1

11.70

10.41

u/ml

0.07

186

Alcohol dependence

212

2562

0.82

2.09

1.1

1.96

5.77

u/ml

—

353

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

710

1.35

2.09

1.1

7.88

5.18

u/ml

—

Malignant melanoma of skin, including Hilmo

1226

0.75

2.08

1.1

3.71

9.01

u/ml

0.83

119

Superficial injury of thorax

182

1478

1.24

2.08

1.1

7.11

7.27

u/ml

0.02

186

Other/unspecified reactive arthropathies

651

1.36

2.07

1.1

2.48

4.78

u/ml

0.72

Epilepsy

389

3368

1.15

2.07

1.1

4.95

7.53

u/ml

0.84

478

conjunctival haemorrhage

608

1.38

2.07

1.1

8.00

5.65

u/ml

—

Inguinal hernia, bilateral

642

1.36

2.06

1.1

0.85

10.97

u/ml

—

Codes for special purposes

786

7113

1.11

2.06

1.1

4.31

5.89

u/ml

0.75

113

931

Other/unspecified soft tissue disorders related to use, overuse and pressure

270

1.58

2.05

1.2

1.1

3.19

6.00

u/ml

—

Other noninfective disorders of lymphatic vessels and lymph nodes

310

1.53

2.05

1.0

1.1

5.74

5.79

u/ml

—

Infliximab

208

1.67

2.05

1.1

26.60

4.14

u/ml

—

Calcific tendinitis of shoulder

525

1.40

2.04

1.1

1.20

7.61

u/ml

—

Adalimumab

145

1152

1.27

2.04

1.0

1.1

3.80

5.03

u/ml

0.22

178

Dermatopolymyositis, unspecified

2.72

2.03

1.0

1.1

—

20.26

—

Xerosis cutis

111

1.93

2.03

1.2

1.0

—

10.96

—

Excessive earwax

679

5965

1.11

2.03

1.1

4.28

7.09

u/ml

1.54

670

Provisional assignment of new diseases of uncertain etiology

784

7101

1.10

2.03

1.1

4.31

5.87

u/ml

0.73

113

930

Speech and linguistic disorders

159

1226

1.25

2.02

1.1

3.62

6.37

u/ml

0.47

173

Pyoderma gangrenosum

2.21

2.02

1.1

—

9.65

—

Bilateral sagittal split ramus osteotomy operation

402

1.46

2.01

1.0

1.1

7.14

4.36

u/ml

0.39

Other spirochaetal diseases

383

3333

1.15

2.01

1.1

3.80

7.08

u/ml

1.22

407

Viral warts

321

2760

1.17

1.99

1.1

5.42

6.00

u/ml

0.10

381

Inguinal or femoral hernia, bilateral

655

1.35

1.99

1.1

0.83

10.97

u/ml

—

Congenital malformations of breast

218

1.64

1.98

1.0

1.1

0.66

4.38

u/ml

—

Torticollis

164

1.74

1.97

1.1

3.48

8.89

u/ml

—

Overexertion and strenuous or repetitive movements

130

1025

1.28

1.95

1.1

2.85

4.52

u/ml

0.70

139

Inguinal hernia

727

4390

1.11

1.95

1.1

5.44

6.21

u/ml

0.12

585

Hypertrophic scar

624

1.36

1.95

1.1

4.88

2.99

u/ml

—

Crohn's disease of large intestine

530

1.39

1.95

1.1

6.97

3.90

u/ml

—

Primary_lymphoid and hematopoietic malignant neoplasms

239

2009

1.19

1.94

1.1

4.62

8.68

u/ml

1.12

185

Congenital malformations of trachea and bronchus

2.10

1.94

1.1

—

10.11

—

Nephropathy related operations

127

1000

1.28

1.93

1.2

1.1

30.41

7.28

u/ml

0.66

130

Blood alcohol or alcohol intoxication level

253

0.47

1.92

1.0

1.1

—

6.16

—

Corns and callosities

583

1.37

1.91

1.2

1.1

16.10

3.22

u/ml

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

910

6296

1.10

1.91

1.1

5.31

4.57

u/ml

0.17

143

923

Use of anticholinesterases

269

1799

1.18

1.91

1.1

10.12

13.97

u/ml

—

N06DA Anticholinesterases

269

1799

1.18

1.91

1.1

10.12

13.97

u/ml

—

Burns and corrosions of external body surface, specified by site

145

1163

1.25

1.90

1.1

9.14

5.92

u/ml

0.33

166

DVT of lower extremities and pulmonary embolism

449

3949

1.13

1.89

1.1

5.12

8.44

u/ml

1.12

414

Inflammation of lacrimal passages (chronic)

114

1.87

1.89

1.1

—

12.72

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

500

4449

1.13

1.89

1.1

2.86

5.22

u/ml

1.31

696

Acute laryngitis and tracheitis

209

1713

1.21

1.89

1.1

4.52

4.69

u/ml

0.03

266

Retinal detachments and breaks

365

3182

1.15

1.88

1.1

6.17

9.04

u/ml

0.46

321

Anomalies of pupillary function

221

1.61

1.88

1.2

1.1

3.94

6.80

u/ml

—

Maternal care for known or suspected disproportion

612

1.36

1.87

1.1

3.14

4.29

u/ml

0.20

117

Other bursitis of elbow

2.26

1.87

1.0

1.1

—

17.65

—

Other spirochaetal diseases

388

3401

1.14

1.86

1.1

4.57

7.58

u/ml

0.91

417

Left bundle-branch block

526

1.38

1.86

1.1

0.80

5.07

u/ml

—

278

1.53

1.85

1.1

3.14

6.13

u/ml

—

Specific development disorders of speech and language

732

1.31

1.85

1.1

1.08

8.10

u/ml

—

107

Residual foreign body in soft tissue

460

1.40

1.83

1.0

1.1

1.93

5.14

u/ml

—

Autonomic disorders

207

1.62

1.82

1.1

20.02

5.10

u/ml

—

Hypertrophic disorders of skin

684

1.33

1.82

1.1

4.88

3.45

u/ml

—

102

Disorders of psychological development

221

1724

1.20

1.81

1.1

3.27

5.54

u/ml

0.48

245

Alzheimer’s disease (Atypical or mixed), excluding more controls

298

1.45

1.80

1.1

—

26.06

—

Any dementia, excluding more controls

292

1723

1.17

1.80

1.1

7.40

12.04

u/ml

—

Fall on and from ladder

555

1.36

1.80

1.1

7.42

6.49

u/ml

0.07

Other psoriatic arthropathies

126

1002

1.27

1.79

1.0

1.1

1.32

5.41

u/ml

2.41

129

Prolapse and hernia of ovary and fallopian tube

221

1.58

1.79

1.1

—

5.27

—

Benign neoplasm: Skin, unspecified

337

1.47

1.79

1.1

9.76

6.63

u/ml

—

Malignant neoplasm of thyroid gland, including Hilmo

100

774

1.30

1.77

1.0

1.1

2.01

5.61

u/ml

1.54

Malignant neoplasm of thyroid gland

678

1.32

1.77

1.0

1.1

2.21

5.28

u/ml

1.03

Intrahepatic Cholestasis of Pregnancy (ICP)

127

1014

1.26

1.77

1.1

7.72

4.42

u/ml

0.20

167

Infectious mononucleosis

156

1274

1.23

1.77

1.1

2.77

4.69

u/ml

0.87

196

Melanocytic naevi, other sites/unspecified

108

845

1.29

1.76

1.1

15.19

3.93

u/ml

0.67

121

Liver disorders in diseases classified elsewhere

2.80

1.76

1.0

1.1

—

4.84

—

Arthropathic psoriasis

137

1103

1.25

1.76

1.1

1.88

6.23

u/ml

1.78

143

Herpesviral keratitis and keratoconjunctivitis

372

1.44

1.75

1.1

7.02

6.14

u/ml

—

Osteonecrosis

507

1.37

1.74

1.1

1.97

5.09

u/ml

—

Subacute thyroiditis

356

1.45

1.74

1.1

0.66

3.67

u/ml

—

Type 2 diabetes

1543

8446

1.07

1.73

1.1

4.26

5.35

u/ml

0.66

132

1210

Alcohol use disorder, ICD-based

405

4576

0.88

1.73

1.1

5.45

6.22

u/ml

0.11

657

Intermittent heterotropia

724

1.31

1.73

1.1

3.29

6.16

u/ml

0.73

107

Single delivery by caesarean section

363

1821

1.15

1.72

1.1

6.86

4.29

u/ml

0.35

319

Epileptic seizures related to alcohol

0.00

1.72

0.0

1.1

—

6.27

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

440

4919

0.89

1.72

1.1

5.38

6.16

u/ml

0.12

704

Inflammatory disorders of breast

110

867

1.28

1.71

1.1

4.02

4.58

u/ml

0.11

140

Obesity, other/unspecified

537

4830

1.12

1.71

1.1

4.36

5.55

u/ml

0.35

724

Malignant melanoma, including Hilmo

118

1478

0.80

1.71

1.1

4.32

9.79

u/ml

0.94

146

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1572

10064

1.07

1.70

1.1

7.44

5.32

u/ml

0.71

153

1377

Antenatal screening

444

2210

1.13

1.70

1.1

4.80

4.70

u/ml

0.02

374

Embedded and impacted teeth

528

3914

1.12

1.70

1.1

3.21

4.18

u/ml

0.64

595

Secondary parkinsonism, excluding more controls

141

1.72

1.69

1.2

1.1

—

7.86

—

Helminthiases

451

1.39

1.69

1.0

1.1

2.58

4.63

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

401

3108

0.88

1.68

1.1

9.05

10.19

u/ml

0.09

274

Malignant neoplasm of colon

137

1109

1.24

1.68

1.1

7.74

9.73

u/ml

0.16

Moderate visual impairment, monocular

2.53

1.67

1.1

—

15.11

—

Malignant neoplasm of rectum

666

1.31

1.67

1.0

1.1

1.50

8.75

u/ml

—

Injury of blood vessels of thorax

2.90

1.67

1.0

1.1

—

4.12

—

Other and unspecified psoriasis

554

1.35

1.67

1.1

2.64

5.00

u/ml

—

Localized adiposity

2.32

1.67

1.1

—

3.01

—

Thoracic aortic aneurysm

121

967

1.26

1.66

1.1

7.51

7.70

u/ml

—

Heart failure and coronary heart disease

367

2283

1.14

1.66

1.2

1.1

23.33

9.75

u/ml

0.97

178

Primary open-angle glaucoma

285

2384

1.16

1.66

1.1

3.95

11.33

u/ml

1.55

148

Hirsutism in women

253

1.53

1.66

1.1

6.22

3.66

u/ml

—

Anogenital herpesviral [herpes simplex] infection

192

1612

1.20

1.66

1.1

3.53

4.51

u/ml

0.32

256

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

813

6495

1.09

1.66

1.1

4.80

4.71

u/ml

0.01

959

Injuries to the head

1831

10624

1.06

1.65

1.1

4.56

5.40

u/ml

0.53

205

1437

Lyme disease

372

3284

1.14

1.64

1.1

2.90

7.04

u/ml

2.17

399

Spirochaetal infections, other/unspecified

377

3331

1.14

1.64

1.1

3.71

7.14

u/ml

1.34

405

Basal cell carcinoma

380

2977

0.88

1.64

1.1

9.74

9.94

u/ml

0.01

256

Other and unspecified degenerative diseases of nervous system

150

1.68

1.64

1.1

—

9.64

—

Exposure to smoke, fire and flames

213

1.57

1.64

1.1

0.52

8.54

u/ml

—

Primary angle-closure glaucoma

286

1.48

1.63

1.2

1.1

21.16

9.07

u/ml

—

Viral pneumonia

153

1259

1.22

1.62

1.1

16.11

6.20

u/ml

0.71

157

Corticotropin deficiency

2.00

1.62

1.2

1.1

—

8.85

—

Other disorders of breast

191

1607

1.20

1.61

1.1

1.54

6.67

u/ml

2.93

210

Crohn's disease NAS

671

1.31

1.61

1.1

4.31

3.78

u/ml

—

105

Vascular dementia

421

1.38

1.61

1.0

1.1

—

26.92

—

Deep bite that required surgery

144

1.70

1.60

1.0

1.1

7.94

1.68

u/ml

—

Aortic valve malfunction, age under 60 years

107

848

1.27

1.60

1.1

3.62

5.99

u/ml

0.49

134

Ectopic pregnancy

271

2349

1.16

1.59

1.1

2.67

5.01

u/ml

1.18

364

Malignant neoplasm of prostate, including Hilmo

168

1201

0.83

1.58

1.1

3.29

9.05

u/ml

1.57

120

Complications associated with artificial fertilization

248

1.52

1.58

1.1

2.78

4.41

u/ml

—

Sleep disorders, other/unspecified

389

1.40

1.57

1.1

1.28

6.21

u/ml

—

Spasmodic torticollis

297

1.46

1.57

1.1

12.04

6.33

u/ml

—

Malignant neoplasm of rectum, including Hilmo

114

912

1.26

1.57

1.0

1.1

1.39

9.41

u/ml

—

Mixed conductive and sensorineural hearing loss

119

957

1.25

1.57

1.1

19.19

6.51

u/ml

—

Bitten or struck by other mammals

172

1438

1.20

1.57

1.1

3.51

5.42

u/ml

0.37

215

Myocardial infarction, without ST-elevation

344

2760

1.14

1.57

1.1

20.38

11.82

u/ml

0.34

212

Other appendicitis

109

869

1.26

1.56

1.1

3.02

4.26

u/ml

—

117

Bacterial, viral and other infectious agents

112

896

1.26

1.56

1.1

1.50

5.99

u/ml

1.90

131

Myocarditis

389

1.40

1.56

1.1

2.15

7.53

u/ml

0.86

Benign leiomyoma with endometriosis

193

1631

1.19

1.56

1.1

7.01

7.10

u/ml

0.01

176

Sarcoidosis

154

1275

1.21

1.55

1.1

3.60

8.37

u/ml

1.40

154

Other and unspecified corneal deformities and disorders

298

1.46

1.55

1.1

9.28

6.56

u/ml

—

All pneumoniae

1629

10271

1.06

1.53

1.1

7.83

5.19

u/ml

0.94

157

1409

Other specified and unspecified personality disorders

128

1042

1.24

1.53

1.1

2.31

4.71

u/ml

1.04

169

Preterm labour and delivery

412

3681

1.12

1.52

1.1

4.33

5.06

u/ml

0.21

547

Open bite

713

1.29

1.52

1.2

1.1

2.53

6.29

u/ml

1.25

108

Viral infections of the central nervous system

748

1.28

1.52

1.1

4.00

3.76

u/ml

—

105

Divergent concomitant strabismus

105

837

1.26

1.52

1.1

1.06

4.76

u/ml

2.68

122

Maxillary retrognathism

218

1.54

1.51

1.0

1.1

1.75

8.72

u/ml

—

Other specified disorders of external ear

250

1.49

1.51

1.0

1.1

4.70

8.57

u/ml

—

Myeloproliferative diseases (CML excluded)

599

1.31

1.51

1.2

1.1

15.76

6.10

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

1616

10240

1.06

1.51

1.1

7.73

5.21

u/ml

0.88

157

1404

Juvenile cataract

2.52

1.50

1.2

1.0

—

1.06

—

Benign neoplasm of bone and articular cartilage

108

865

1.26

1.50

1.1

0.81

4.21

u/ml

—

120

Assault

197

1675

1.18

1.50

1.1

3.20

5.30

u/ml

0.58

281

Psoriatic arthropathies, ICD10

127

1036

1.23

1.49

1.0

1.1

1.32

5.32

u/ml

2.45

135

Viral warts

136

1118

1.22

1.49

1.1

10.63

4.56

u/ml

0.64

159

Contact with other hot fluids

326

1.43

1.49

1.1

18.88

6.03

u/ml

—

Pedal cyclist injured in other and unspecified transport accidents

146

1209

1.21

1.49

1.1

3.91

5.34

u/ml

0.23

160

Fracture at wrist and hand level

487

4390

1.11

1.48

1.1

3.16

6.31

u/ml

1.56

648

Desensitization to allergens

752

1.27

1.47

1.1

3.77

4.83

u/ml

0.23

123

Malignant neoplasm of endocrine gland

734

1.28

1.47

1.1

2.13

5.72

u/ml

1.46

Benign neoplasm: Connective and other soft tissue, unspecified

102

1.80

1.47

1.1

—

8.24

—

Other bacterial diseases

1372

8672

1.06

1.46

1.1

8.86

5.76

u/ml

0.69

123

1145

Monoarthritis, not elsewhere classified

369

1.39

1.46

1.0

1.1

0.90

4.54

u/ml

—

Later onset COPD, excluding more controls

154

988

1.21

1.46

1.1

5.90

20.31

u/ml

—

malignant neoplasm of male genital organs

171

1239

0.84

1.45

1.1

3.39

8.87

u/ml

1.49

124

Other viral diseases, not elsewhere classified

264

2295

1.15

1.45

1.1

9.67

7.15

u/ml

0.18

315

Obstructed labour due to maternal pelvic abnormality

214

1838

1.17

1.45

1.1

4.75

6.71

u/ml

0.46

258

Down's syndrome

2.34

1.43

1.1

—

2.64

—

Poor fetal growth

244

2122

1.16

1.42

1.1

7.88

4.50

u/ml

0.58

355

Hyperprolactinaemia

432

1.36

1.41

1.0

1.1

7.13

4.59

u/ml

—

Idiopathic hypercalciuria

2.14

1.41

1.2

1.1

—

12.84

—

Colon adenocarcinoma

103

827

1.25

1.41

1.1

9.23

8.18

u/ml

—

Coxarthrosis, primary, with hip surgery

457

3860

1.11

1.41

1.1

5.39

10.13

u/ml

1.42

324

Campylobacter enteritis

255

1.47

1.40

1.1

2.68

6.73

u/ml

—

Malignant neoplasm of prostate

160

1140

0.84

1.39

1.1

3.44

10.17

u/ml

1.68

103

Artificial joint operation, meniscal resection

1189

7239

1.07

1.39

1.1

7.76

6.12

u/ml

0.29

132

891

Abnormal spermatozoa

679

0.73

1.39

1.2

1.1

3.07

11.57

u/ml

1.60

L04AC Interleukin inhibitors

625

1.29

1.39

1.1

0.66

4.48

u/ml

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

391

1.37

1.2

1.1

4.46

4.52

u/ml

0.01

Basal cell carcinoma, including avohilmo

409

3135

0.90

1.37

1.1

8.81

10.05

u/ml

0.12

279

Sequelae of cerebrovascular disease

326

2493

1.13

1.37

1.1

6.74

10.40

u/ml

0.70

221

Seropositive rheumatoid arthritis, wide

307

2716

1.13

1.37

1.1

3.96

8.35

u/ml

1.85

305

Cleft lip, lip and palate or palate

191

1.54

1.37

1.1

5.10

4.94

u/ml

—

Other puerperal infections

151

1268

1.20

1.37

1.1

1.57

4.11

u/ml

2.11

208

Unspecified mental disorder

607

5567

1.09

1.36

1.1

4.99

5.91

u/ml

0.31

824

Bell's palsy

135

1121

1.21

1.36

1.1

15.96

5.81

u/ml

0.36

152

Coronary atherosclerosis

699

4071

1.09

1.36

1.1

13.53

7.50

u/ml

0.63

442

Crossbite

120

911

1.23

1.35

1.1

2.44

6.68

u/ml

1.29

118

Heart failure and bmi 25plus

325

1944

1.13

1.35

1.1

23.50

6.80

u/ml

0.83

152

Hydrocephalus in other diseases

0.00

1.35

0.0

1.1

—

15.11

—

Chalazion

142

1186

1.20

1.35

1.1

4.67

7.23

u/ml

0.37

154

Sequelae of other external causes

505

1.32

1.34

1.1

0.88

5.22

u/ml

—

Peripheral artery operations in Hilmo

102

823

1.24

1.34

1.2

1.1

39.01

8.25

u/ml

—

Delivery

649

3143

1.09

1.34

1.1

6.42

5.59

u/ml

0.14

397

Open wound of forearm

118

970

1.22

1.33

1.1

1.96

5.00

u/ml

—

125

Amputation of toe

445

1.33

1.32

1.2

1.1

54.02

8.78

u/ml

—

Hordeolum and other deep inflammation of eyelid

621

1.28

1.32

1.1

3.43

5.45

u/ml

—

All dysplastic lesions of the vulva

464

1.33

1.31

1.0

1.1

31.59

4.57

u/ml

—

Wet age-related macular degeneration

134

1082

1.20

1.31

1.1

33.88

15.88

u/ml

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

326

1.39

1.31

1.2

1.1

0.69

7.12

u/ml

—

Hyperosmolality and hypernatraemia

1.87

1.31

1.1

1.0

—

17.10

—

Melanocytic naevi of lower limb, including hip

447

1.33

1.30

1.1

2.98

5.22

u/ml

0.33

Other specified and unspecified disorders of eye and adnexa

335

1.38

1.30

1.1

2.68

5.80

u/ml

—

Scabies

212

1838

1.16

1.30

1.1

10.76

5.03

u/ml

0.29

258

Hypertrichosis

285

1.42

1.30

1.1

7.52

3.62

u/ml

—

All kidney diseases

1558

10095

1.06

1.29

1.1

8.49

4.99

u/ml

1.12

153

1398

Severe visual impairment, monocular

1.97

1.29

1.1

—

14.88

—

Viral infections of the central nervous system

101

820

1.24

1.29

1.1

2.96

3.72

u/ml

—

113

Focal brain injury

447

1.33

1.29

1.1

2.85

9.18

u/ml

—

Papillary adenocarcinoma of thyroid gland

509

1.31

1.28

1.1

2.16

5.14

u/ml

0.90

Foreign body in respiratory tract

509

1.31

1.28

1.0

1.1

6.85

5.94

u/ml

—

Molar incisor enamel hypoplasia, with caries

118

0.41

1.27

1.2

1.1

—

10.60

—

Other symptoms and signs involving the urinary system

103

839

1.23

1.27

1.1

6.88

6.53

u/ml

—

Atopic conjunctivitis

484

1.31

1.27

1.1

1.04

5.53

u/ml

—

Foreign body entering into or through eye or natural orifice

768

1.24

1.26

1.1

7.13

5.52

u/ml

0.11

Pseudopolyposis of colon

2.48

1.26

1.2

1.1

—

5.30

—

Dermatitis due to ingested food

473

1.31

1.26

1.1

3.39

3.66

u/ml

—

Chronic periodontitis, including avohilmo

1415

8979

1.06

1.25

1.1

7.89

5.35

u/ml

0.54

126

1200

Primary open-angle glaucoma, strict

229

1998

1.15

1.24

1.1

4.29

12.05

u/ml

—

128

Contact with heat and hot substances

556

1.29

1.24

1.1

20.63

5.23

u/ml

—

Periodontitis

1420

8994

1.06

1.24

1.1

7.84

5.34

u/ml

0.54

127

1202

Other infectious diseases

797

1.24

1.2

1.1

5.39

5.17

u/ml

0.03

Primary ovarian failure

229

1.46

1.24

1.0

1.1

3.96

5.79

u/ml

—

Single spontaneous delivery

640

3123

1.09

1.23

1.1

5.98

5.59

u/ml

0.07

395

Valvular operations

118

978

1.21

1.23

1.1

3.73

7.22

u/ml

—

101

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

299

2663

1.13

1.23

1.1

3.78

8.38

u/ml

1.93

302

Late syphilis

116

1.66

1.23

1.0

1.1

—

8.43

—

Degenerative diseases of the nervous system

274

1778

1.13

1.23

1.1

10.12

11.88

u/ml

—

Other dermatomyositis

2.22

1.23

1.1

—

16.98

—

Contusion of other and unspecified parts of foot

602

1.27

1.22

1.1

3.49

6.04

u/ml

0.45

Ulcerative rectosigmoiditis

104

853

1.23

1.22

1.0

1.1

0.88

4.08

u/ml

—

126

Injury of muscle and tendon at forearm level

172

1.53

1.22

1.0

1.1

2.37

5.30

u/ml

—

Persons encountering health services for specific procedures, not carried out

931

0.79

1.21

1.1

7.94

6.66

u/ml

0.09

137

Explicit bacterial Sepsis

107

880

1.22

1.21

1.1

5.48

5.75

u/ml

—

100

Rheumatic valve diseases

143

0.49

1.21

1.0

1.1

—

9.54

—

Hyperlipidaemia, other/unspecified

372

3088

1.11

1.21

1.1

2.20

9.80

u/ml

5.29

290

Other complications of labour and delivery, not elsewhere classified

187

1979

0.86

1.21

1.1

2.78

2.98

u/ml

0.09

331

Ovarian hyperstimulation (induction)

256

1.43

1.20

1.1

2.78

3.38

u/ml

—

2.37

1.20

1.0

1.1

—

1.09

—

All dysplastic lesions of the vagina

281

1.40

1.20

1.1

1.60

5.50

u/ml

—

Injury of eye and orbit

186

1609

1.16

1.20

1.1

1.77

5.74

u/ml

2.79

251

Vertical strabismus

315

1.38

1.19

1.2

1.1

0.58

5.92

u/ml

—

Other osteochondropathies

684

1.25

1.19

1.0

1.1

2.49

6.90

u/ml

—

102

Diastasis of muscle

1.74

1.19

1.2

1.1

—

11.92

—

L01XX Other antineoplastic agents

401

1.33

1.19

1.2

1.1

0.78

6.82

u/ml

—

Family history of certain disabilities and chronic diseases leading to disablement

640

1.26

1.19

1.1

2.81

4.83

u/ml

—

112

Juvenile osteochondrosis

393

1.34

1.19

1.1

1.56

5.96

u/ml

—

Benign neoplasm: Spinal cord

125

1.62

1.19

1.3

1.1

4.78

12.24

u/ml

—

Lesion of ulnar nerve

150

1277

1.18

1.2

1.1

6.02

6.94

u/ml

0.10

185

Myeloproliferative diseases

658

1.25

1.18

1.2

1.1

15.76

5.72

u/ml

—

Liquid cancers, helper endpoint

421

3337

1.10

1.18

1.1

8.25

7.94

u/ml

0.03

340

Maternal care for cervical incompetence

420

1.32

1.17

1.1

0.70

4.67

u/ml

—

Enterobiasis

274

1.41

1.17

1.0

1.1

3.29

5.48

u/ml

—

Hypothermia

128

0.46

1.17

1.0

1.1

—

3.28

—

Henoch-Schönlein purpura nephritis (HSPN)

2.11

1.17

1.1

1.2

—

17.62

—

Unspecified privation

127

1067

1.20

1.17

1.1

18.71

4.65

u/ml

1.05

128

Left ventricular outflow tract obstruction (LVOTO), broad definition

112

930

1.21

1.17

1.1

3.41

6.11

u/ml

0.63

145

Other sexually transmitted chlamydial diseases

119

995

1.20

1.17

1.0

1.1

2.15

3.56

u/ml

0.61

171

Heart failure, strict

550

3566

1.09

1.17

1.1

22.71

7.93

u/ml

1.15

298

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

2.59

1.16

1.2

1.1

—

7.52

—

Onychogryphosis

2.58

1.16

1.2

1.1

—

Toxic effects of substances chiefly nonmedicinal as to source

146

1243

1.18

1.16

1.0

1.1

1.13

5.64

u/ml

3.78

182

Event of undetermined intent

687

1.24

1.16

1.1

2.24

4.57

u/ml

—

Contusion of toe(s) without damage to nail

266

1.41

1.16

1.1

6.75

5.41

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

723

1.24

1.15

1.1

4.61

8.12

u/ml

—

Other or ill-defined heart diseases

447

1.30

1.15

1.1

1.0

1.87

4.08

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

301

2695

1.12

1.15

1.1

3.78

8.36

u/ml

1.93

304

Caught, crushed, jammed or pinched in or between objects

527

1.28

1.15

1.1

5.02

5.84

u/ml

—

Ankylosing spondylitis, ICD10

108

896

1.21

1.15

1.1

2.52

5.64

u/ml

—

125

Other endocrine disorders

616

1.25

1.14

1.1

0.87

9.07

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

127

1072

1.19

1.13

1.1

7.72

5.56

u/ml

0.12

178

Contracture of joint

111

1.64

1.13

1.1

—

1.52

—

Prolonged pregnancy

299

2343

1.12

1.13

1.1

5.71

3.39

u/ml

0.63

434

LeFortI or BSSO operation

502

1.29

1.13

1.0

1.1

7.14

3.69

u/ml

0.55

Pedestrian injured in transport accident

663

1.24

1.12

1.1

9.42

4.31

u/ml

0.46

Abscess of anal and rectal regions

762

1.23

1.12

1.2

1.1

8.36

6.92

u/ml

0.11

109

Problems related to lifestyle

140

1193

1.18

1.11

1.1

1.04

5.30

u/ml

—

188

Injury of muscle and tendon at lower leg level

161

1387

1.16

1.11

1.1

6.75

6.69

u/ml

0.01

186

Foreign body on external eye

167

1443

1.16

1.11

1.1

9.26

4.69

u/ml

0.56

219

Thrombocytopenia, unspecified

601

1.25

1.11

1.1

1.00

6.28

u/ml

—

Follicular lymphoma, hilmo

305

0.65

1.11

1.3

1.1

—

6.49

—

Third [oculomotor] nerve palsy

137

0.51

1.10

1.0

1.1

—

8.47

—

Late syphilis

144

1.55

1.10

1.0

1.1

—

7.36

—

Open wound of lower leg

177

1539

1.15

1.09

1.1

10.52

6.12

u/ml

0.22

182

Other diseases of blood and blood-forming organs

585

1.25

1.09

1.2

1.1

36.16

5.81

u/ml

—

Presbyopia

621

1.25

1.09

1.2

1.1

9.18

5.01

u/ml

0.35

Other diseases of pleura

422

3379

1.10

1.08

1.1

7.05

8.93

u/ml

0.32

313

Other disorders of amniotic fluid and membranes

251

2182

1.13

1.08

1.1

1.98

3.32

u/ml

1.16

404

Other and unspecified erythematous conditions

287

1.37

1.08

1.1

2.53

6.67

u/ml

—

Hypoplasia of dental enamel

123

0.48

1.07

1.2

1.1

—

15.12

—

Kidney transplant status

480

1.28

1.06

1.1

46.72

6.08

u/ml

—

Major coronary heart disease event excluding revascularizations

609

3763

1.08

1.06

1.1

15.72

8.04

u/ml

0.69

381

Scissor bite

397

1.31

1.06

1.1

1.59

8.68

u/ml

—

Digestive system disorders of fetus and newborn

2.43

1.06

1.2

1.1

—

Other and unspecified myopathies

686

1.23

1.06

1.1

12.08

7.49

u/ml

—

Benign neoplasm of middle ear and respiratory system

623

1.24

1.06

1.2

1.1

1.61

6.83

u/ml

1.82

Short stature starting before birth

1.90

1.06

1.4

1.1

—

16.34

—

Maternal care for known or suspected fetal abnormality and damage

299

2315

1.11

1.05

1.1

3.65

3.86

u/ml

0.05

427

663

6418

0.93

1.04

1.1

4.31

5.96

u/ml

0.56

899

Acquired keratosis [keratoderma] palmaris et plantaris

2.11

1.04

1.0

—

3.27

—

Dilated cardiomyopathy

845

0.80

1.04

1.2

1.1

12.41

7.49

u/ml

—

Anisometropia and aniseikonia

290

1.36

1.02

1.0

1.1

1.50

8.75

u/ml

—

Other inflammation of vagina/vulva

466

1.28

1.02

1.1

1.23

3.97

u/ml

1.04

All-cause Heart Failure

538

3514

1.08

1.02

1.1

23.25

8.07

u/ml

1.15

291

Substance abuse

699

7014

0.93

1.01

1.1

8.66

5.53

u/ml

0.34

1004

Renal tubulo-interstitial diseases

1279

9062

1.05

1.01

1.1

9.48

5.42

u/ml

0.91

109

1183

Persons with potential health hazards related to communicable diseases

587

6247

0.93

1.01

1.1

4.64

5.15

u/ml

0.12

975

Background retinopathy and retinal vascular changes

172

1.47

1.01

1.0

1.1

—

7.05

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.74

1.00

1.0

1.1

—

2.95

—

Gonarthrosis, primary, with knee surgery

585

4329

1.08

1.00

1.1

6.41

9.37

u/ml

0.39

432

Poisoning by medicine

330

2998

1.10

1.00

1.1

3.52

5.74

u/ml

0.78

461

Focal epilepsy, strict definition

179

2036

0.88

0.99

1.1

5.77

7.74

u/ml

0.27

252

Gestational [pregnancy-induced] hypertension

464

4274

1.09

0.99

1.1

2.32

4.66

u/ml

2.41

682

Labour and delivery complicated by umbilical cord complications

628

0.77

0.99

1.1

0.63

4.08

u/ml

—

Poisoning by drugs, medicaments and biological substances

368

3365

1.10

0.98

1.1

3.96

5.50

u/ml

0.47

512

Mental and behavioural disorders due to psychoactive substance use

727

7174

0.94

0.98

1.1

8.38

5.50

u/ml

0.34

1019

Sequelae of injuries of head

468

1.27

0.98

1.1

2.77

4.93

u/ml

—

Non-follicular lymphoma

702

1.22

0.98

1.1

4.54

7.84

u/ml

—

Pediculosis, acariasis and other infestations

235

2100

1.12

0.98

1.1

11.36

5.46

u/ml

0.37

297

Other specified disorders of kidney and ureter

275

1.36

0.98

1.2

1.1

20.20

6.31

u/ml

—

Specific developmental disorder of motor function

206

0.61

0.98

1.0

1.1

—

7.37

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

134

1154

1.17

0.97

1.1

7.40

5.52

u/ml

0.11

178

Any dementia

309

1942

1.11

0.97

1.1

7.40

12.72

u/ml

—

Abnormal findings on diagnostic imaging of central nervous system

478

1.26

0.97

1.1

2.67

5.15

u/ml

—

Multiple gestation

156

1360

1.15

0.97

1.1

6.21

3.63

u/ml

0.44

262

Periodontal disease, other/unspecified

250

1.37

0.97

1.1

3.38

6.01

u/ml

—

Tuberculosis of other organs, strict

157

1.48

0.96

1.1

—

11.10

—

Bacterial, viral and other infectious agents

116

988

1.18

0.96

1.1

1.44

5.79

u/ml

2.15

147

Other specific arthropathies, wide

199

1.42

0.96

1.1

3.06

7.88

u/ml

—

296

0.68

0.96

1.1

4.98

8.21

u/ml

—

Benign neoplasm of mouth and pharynx

115

979

1.18

0.96

1.1

1.43

5.16

u/ml

2.13

108

Other congenital malformations

185

1631

1.14

0.96

1.1

2.45

5.65

u/ml

2.17

237

Drug-induced tremor

1.79

0.95

1.0

1.1

—

4.10

—

Disorders of male genital organs in diseases classified elsewhere

1.79

0.95

1.1

1.0

—

5.51

—

713

6684

0.94

0.95

1.1

4.07

5.95

u/ml

0.74

947

Disorders of magnesium metabolism

1.79

0.95

1.1

1.2

—

16.98

—

Benign neoplasm: Skin of eyelid, including canthus

162

1417

1.15

0.95

1.0

1.1

6.19

7.93

u/ml

0.17

140

Asthma mixed form (mode)

470

1.26

0.95

1.1

1.54

5.02

u/ml

—

Gout due to impairment of renal function

1.80

0.95

1.2

1.1

—

16.78

—

Other disorders of cornea

107

907

1.18

0.94

1.1

5.79

5.87

u/ml

0.01

101

Contact with and exposure to communicable diseases

491

5266

0.93

0.94

1.1

4.94

5.06

u/ml

0.02

831

Pre-eclampsia superimposed on chronic hypertension

1.76

0.94

1.1

—

0.72

—

Acute alcohol intoxication

233

2599

0.89

0.94

1.1

3.09

6.32

u/ml

1.61

358

Motor disorders

207

0.62

0.94

1.0

1.1

—

8.26

—

Brain glioblastoma and astrocytoma

146

0.54

0.93

1.0

1.1

—

10.83

—

Tuberculosis of other organs

142

1.49

0.93

1.1

—

12.09

—

Amiodarone users

689

0.80

0.93

1.2

1.1

14.18

8.72

u/ml

—

Other sexually transmitted chlamydial diseases

188

1666

1.13

0.92

1.0

1.1

1.66

4.11

u/ml

2.34

260

Nontoxic single thyroid nodule

726

1.20

0.92

1.1

0.88

6.42

u/ml

—

Symptoms and signs involving emotional state

314

1.32

0.91

1.0

1.1

0.86

6.15

u/ml

—

Mental and behavioural disorders due to cannabinoids

371

0.72

0.90

1.0

1.1

—

3.41

—

Traumatic amputation of wrist and hand

314

1.31

0.90

1.0

1.1

8.28

8.48

u/ml

—

Thalassaemia

1.96

0.90

1.1

—

15.06

—

Other drug-induced secondary parkinsonism

1.72

0.90

1.1

—

13.02

—

Sequelae of other and unspecified infectious and parasitic diseases

563

0.78

0.90

1.1

0.68

3.29

u/ml

—

Other arterial embolism and thrombosis

185

1.41

0.90

1.0

1.1

—

8.42

—

Malignant neoplasm of other and unspecified female genital organs

128

0.54

0.89

1.1

—

9.44

—

341

0.72

0.89

1.1

4.98

13.88

u/ml

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

220

1.38

0.88

1.1

12.64

6.95

u/ml

—

malignant neoplasm of female genital organs

132

1507

0.87

0.88

1.1

3.56

9.14

u/ml

1.41

138

Melanocytic naevi of trunk

149

1306

1.15

0.87

1.1

4.01

4.61

u/ml

0.10

181

Early lumbar disc prolapse operation

158

1391

1.14

0.87

1.1

4.83

4.88

u/ml

0.01

239

Tubulo-interstitial nephritis, not specified as acute or chronic

621

1.21

0.87

1.1

5.04

7.09

u/ml

—

Pedestrian injured in collision with pedal cycle

290

1.32

0.87

1.1

5.72

6.40

u/ml

—

Effects of air pressure and water pressure

1.85

0.87

1.0

1.1

—

3.57

—

Complications peculiar to reattachment and amputation

1.84

0.86

1.1

1.2

—

16.82

—

Demyelinating diseases of the central nervous system

121

1046

1.16

0.86

1.1

1.24

4.32

u/ml

2.51

157

Specific development disorders of scholastic skills

623

1.21

0.86

1.1

4.89

7.38

u/ml

—

105

Asthma mixed form (mode), excluding more controls

477

1.24

0.86

1.1

1.54

5.44

u/ml

—

Benign neoplasm: Conjunctiva

282

1.32

0.86

1.1

0.64

7.44

u/ml

—

Loose body in joint

187

1.40

0.86

1.1

5.24

8.08

u/ml

—

Other disorders of central nervous system

104

1.56

0.85

1.1

—

3.55

—

Other and unspecified injuries of thorax

179

0.61

0.85

1.1

—

8.24

—

Sequelae of burns, corrosions and frostbite

1.81

0.85

1.0

1.1

—

5.20

—

MS-disease / Multiple Sclerosis

105

899

1.17

0.85

1.2

1.1

1.31

3.48

u/ml

1.69

143

Cholinergic urticaria

1.81

0.85

1.0

1.1

—

1.20

—

Malignant neoplasm of anus and anal canal, including Hilmo

1.64

0.85

1.2

1.1

—

15.24

—

Other erythematous conditions

327

1.29

0.84

1.1

2.53

7.18

u/ml

—

Other abnormal findings of blood chemistry

398

1.26

0.84

1.1

0.83

1.67

u/ml

—

Burns and corrosions confined to eye and internal organs

292

1.31

0.84

1.0

1.1

1.72

6.03

u/ml

—

Sequelae of transport accidents

1.77

0.83

1.0

1.1

—

15.13

—

Nosocomial condition (hospital)

1.77

0.83

1.3

1.1

—

17.15

—

Benign neoplasm: Skin of trunk

381

1.27

0.83

1.1

2.16

5.76

u/ml

0.79

Pigmented purpuric dermatosis

1.67

0.82

1.1

1.0

—

1.21

—

Malignant neoplasm of ovary, including Hilmo

622

0.80

0.82

1.1

2.48

7.55

u/ml

—

Schizophrenia or delusion, excluding more controls

414

3803

1.08

0.82

1.1

15.51

5.89

u/ml

0.50

606

Other obstructed labour

112

968

1.16

0.82

1.1

2.52

6.65

u/ml

1.38

154

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

458

3337

0.93

0.82

1.1

8.14

9.31

u/ml

0.11

313

Chronic iridocyclitis

490

1.23

0.81

1.0

1.1

2.33

5.50

u/ml

—

Assault by hanging, strangulation and suffocation

1.87

0.80

1.0

1.1

—

21.00

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

0.80

0.0

1.2

—

20.52

—

Early onset COPD

215

1940

1.11

0.80

1.1

15.88

7.76

u/ml

0.27

233

Other diseases caused by chlamydiae

173

1.40

0.80

1.1

0.70

6.74

u/ml

—

Congenital malformations of uterus and cervix

286

1.31

0.80

1.1

2.78

5.27

u/ml

—

Complications of other internal prosthetic devices, implants and grafts

321

1.28

0.79

1.1

0.96

6.91

u/ml

—

Unspecified human immunodeficiency virus [HIV] disease

0.50

0.79

1.0

1.1

—

3.37

—

Ascites

519

1.22

0.79

1.1

7.26

6.54

u/ml

—

Malignant neoplasm of colon, including Hilmo

164

1457

1.13

0.79

1.1

6.03

11.74

u/ml

0.79

116

Hyperfunction of pituitary gland

611

1.20

0.79

1.1

6.20

4.06

u/ml

—

Eustachian salpingitis and obstruction

118

1028

1.15

0.78

1.0

1.1

1.52

3.11

u/ml

1.53

163

Benign neoplasm: Duodenum

182

1.38

0.78

1.0

1.1

—

7.09

—

Unicornuate uterus

1.81

0.77

1.0

—

12.56

—

Peripheral artery disease

372

2741

1.08

0.77

1.1

28.08

9.97

u/ml

0.71

215

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

1.80

0.77

1.0

—

9.08

—

Acanthosis nigricans

1.80

0.77

1.0

—

20.90

—

Retinal breaks without detachment

161

1433

1.13

0.77

1.1

5.75

7.50

u/ml

0.19

158

Twin gestation

149

1321

1.13

0.77

1.1

6.21

3.74

u/ml

0.41

252

Acute hepatitis B

1.79

0.77

1.0

1.1

—

4.42

—

Malignant neoplasm of digestive organs

378

2765

1.08

0.77

1.1

5.15

9.46

u/ml

1.28

251

Complications of labour and delivery

1071

5690

1.05

0.77

1.1

6.28

4.96

u/ml

0.28

148

778

Other hereditary haemolytic anaemias

1.73

0.76

1.1

1.0

—

5.79

—

Non-ischemic cardiomyopathy

274

2017

1.09

0.76

1.1

18.83

8.81

u/ml

0.52

168

Pulmonary heart disease, diseases of pulmonary circulation

305

2806

1.09

0.76

1.1

5.12

8.47

u/ml

0.75

277

Sequelae of tuberculosis

1.53

0.76

1.0

1.1

—

28.15

—

Hereditary motor and sensory neuropathy

1.62

0.76

1.0

1.1

—

0.95

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

174

1939

0.89

0.75

1.1

4.34

7.09

u/ml

0.48

241

Explicit fungal Sepsis

1.69

0.75

1.2

1.0

—

3.87

—

Hyperaldosteronism

227

1.33

0.75

1.0

1.1

1.18

4.78

u/ml

—

Contusion of ankle

423

1.24

0.75

1.1

6.38

5.67

u/ml

—

Acute thyroiditis

1.88

0.74

1.1

—

4.23

—

Alzheimer disease

230

1528

1.10

0.74

1.1

10.12

14.68

u/ml

—

Suicide or other Intentional self-harm

355

3293

1.08

0.74

1.1

3.61

5.73

u/ml

0.49

507

Foreign body granuloma of skin and subcutaneous tissue

2.04

0.73

1.0

1.1

—

1.10

—

Corneal ulcer

230

2095

1.10

0.73

1.1

2.06

7.19

u/ml

3.40

290

Visual field defects

718

1.17

0.72

1.1

9.25

5.17

u/ml

—

Speech disturbances, not elsewhere classified

709

1.17

0.72

1.1

2.09

5.82

u/ml

—

Varicella [chickenpox]

471

1.22

0.72

1.1

4.94

7.40

u/ml

0.31

Pneumonia, organism unspecified

1367

9224

1.04

0.71

1.1

7.14

5.39

u/ml

0.51

140

1272

Labyrinthitis

1.96

0.71

1.0

1.1

—

20.26

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

113

975

1.15

0.71

1.1

3.35

4.63

u/ml

0.26

150

Hypermobility syndrome

702

1.17

0.71

1.0

1.1

0.83

3.87

u/ml

—

122

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

510

0.80

0.71

1.0

1.1

1.78

7.24

u/ml

—

Acute appendicitis, with complications

214

1947

1.10

0.70

1.1

8.07

6.82

u/ml

0.15

265

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

114

1297

0.88

0.70

1.1

3.31

8.20

u/ml

1.32

126

Obstructive hydrocephalus

143

0.62

0.70

1.1

—

12.41

—

Diabetes insipidus

1.55

0.70

1.0

1.1

—

15.79

—

Benign neoplasm of other and unspecified female genital organs

400

1.23

0.70

1.0

1.1

1.27

5.82

u/ml

—

Malignant neoplasm of cervix uteri, including Hilmo

257

1.29

0.69

1.1

2.13

7.19

u/ml

—

Disorder of lipoprotein metabolism, unspecified

108

946

1.14

0.68

1.1

9.93

7.88

u/ml

0.16

Corneal scars and opacities

231

1.31

0.68

1.1

9.28

4.90

u/ml

—

Streptococcal septicaemia

695

1.17

0.68

1.1

6.94

6.67

u/ml

—

Tooth agenesis EXCLUDE clefts and syndromes

557

1.19

0.68

1.1

4.45

6.20

u/ml

—

Motor disorders, excluding more controls

181

0.67

0.68

1.0

1.1

—

14.09

—

Nezelof syndrome

1.66

0.68

1.1

—

14.90

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS